<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d515053dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXECUTION VERSION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AGREEMENT AND
PLAN OF MERGER </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AMONG </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ROCHE
HOLDINGS, INC., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ABINGDON ACQUISITION CORP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">IGNYTA, INC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of December&nbsp;21, 2017 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE I THE OFFER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">The Offer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Company Actions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 1.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Merger of Purchaser into the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 1.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Effective Time</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 1.06.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Effects of the Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 1.07.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Certificate of Incorporation and Bylaws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 1.08.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Directors and Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE II EFFECT ON THE CAPITAL STOCK OF THE CONSTITUENT CORPORATIONS; EXCHANGE OF
CERTIFICATES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 2.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Treatment and Conversion of Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 2.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Treatment of Company Warrants</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 2.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Treatment of Company Options and Restricted Stock Units</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 2.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Exchange and Payment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 2.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Withholding Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 2.06.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Adjustments to Prevent Dilution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 2.07.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Dissenting Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 2.08.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Loan Payoff</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 2.09.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Further Action</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE COMPANY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Organization and Qualification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Capitalization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Authority; Board Action</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Conflict; Consents and Approvals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">SEC Reports; Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.06.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Absence of Certain Changes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.07.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Undisclosed Material Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.08.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Brokers; Certain Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.09.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Employee Benefit Matters/Employees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Title to Assets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Compliance with Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.14.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.15.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.16.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Real Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.17.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Material Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.18.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Regulatory Compliance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.19.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.20.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Certain Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.21.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Related Party Transactions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.22.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Opinion of Financial Advisors of the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.23.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Takeover Statutes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.24.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Vote Required</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.25.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Information Supplied</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 3.26.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Other Representations or Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF PARENT AND PURCHASER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 4.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Organization and Qualification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 4.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Authority</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 4.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Conflicts; Consents and Approvals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 4.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 4.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Interested Stockholder</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 4.06.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Sufficient Funds</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 4.07.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Brokers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 4.08.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Other Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE V COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Conduct of Business of the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Solicitation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Access to Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Notices of Certain Events</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Reasonable Best Efforts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.06.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Indemnification, Exculpation and Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.07.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Employee Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.08.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Takeover Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.09.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Stockholder Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Press Releases</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Rule 16b-3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Employee Communications</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Transfer Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.14.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Rule 14d-10 Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 5.15.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Stock Exchange Delisting; Deregistration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VI CONDITIONS PRECEDENT TO THE MERGER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conditions to Each Party&#146;s Obligation To Effect the Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 6.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Injunctions or Legal Restraints; Illegality</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 6.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Consummation of Offer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VII TERMINATION, AMENDMENT AND WAIVER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 7.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 7.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Effect of Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 7.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Fees and Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 7.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Amendment or Supplement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 7.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Extension of Time; Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="5"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VIII GENERAL PROVISIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 8.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Non-Survival of Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 8.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Entire Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 8.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Specific Performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 8.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Submission to Jurisdiction; Waiver of Jury Trial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 8.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 8.06.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Governing Law</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 8.07.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Assignment; Successors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 8.08.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Parties in Interest</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 8.09.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 8.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Counterparts; Facsimile or.pdf Signature</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section 8.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Defined Terms; Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ANNEX I</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-I-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ANNEX II</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">A-II-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">THIS AGREEMENT AND PLAN OF MERGER (this &#147;<U>Agreement</U>&#148;), is made and entered into as of December&nbsp;21, 2017, among Roche
Holdings, Inc, a Delaware corporation (&#147;<U>Parent</U>&#148;), Abingdon Acquisition Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (&#147;<U>Purchaser</U>&#148;), and Ignyta, Inc., a Delaware corporation (the
&#147;<U>Company</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">WHEREAS, Parent has agreed to cause Purchaser to commence a cash tender offer (as it may be amended from time to time as permitted under this
Agreement, the &#147;<U>Offer</U>&#148;) to acquire all of the outstanding shares of Company Common Stock (the &#147;<U>Company Shares</U>&#148;) for $27.00 per share, in cash, without interest, or any higher amount per share paid pursuant to the
Offer (such amount, as may be adjusted in accordance with <U>Section</U><U></U><U>&nbsp;1.1(g)</U>, the &#147;<U>Offer Price</U>&#148;) and upon the terms and subject to the conditions of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">WHEREAS, immediately following the Offer Acceptance Time, upon the terms and conditions set forth herein, Purchaser will be merged with and
into the Company (the &#147;<U>Merger</U>&#148;), with the Company continuing as the surviving corporation in the Merger (the &#147;<U>Surviving Corporation</U>&#148;), on the terms and subject to the conditions set forth in this Agreement, whereby,
except as expressly provided in <U>Section</U><U></U><U>&nbsp;2.01</U> and <U>Section</U><U></U><U>&nbsp;2.07</U>, (i)&nbsp;each issued and outstanding Company Share (other than Excluded Shares and Dissenting Shares) shall be converted into the
right to receive the Offer Price, and (ii)&nbsp;the Company shall become an indirect wholly owned Subsidiary of Parent as a result of the Merger; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company Board has (i)&nbsp;determined that this Agreement and the Transactions, including the Offer and the Merger, are advisable
to, and in the best interest of, the Company and its stockholders, (ii)&nbsp;approved the execution, delivery and performance by the Company of this Agreement and the consummation of the Transactions, including the Offer and the Merger and
(iii)&nbsp;resolved to recommend that the stockholders of the Company tender their Company Shares to Purchaser pursuant to the Offer (the &#147;<U>Company Board Recommendation</U>&#148;), in each case, on the terms and subject to the conditions of
this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">WHEREAS, the board of directors of each of Parent and Purchaser have approved this Agreement and declared it advisable
for Parent and Purchaser, respectively, to enter into this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">WHEREAS, each of Parent, Purchaser and the Company acknowledge and
agree that the Merger shall be governed by, and effected pursuant to, Section&nbsp;251(h) of the DGCL and shall, subject to satisfaction of the conditions set forth in this Agreement, be consummated immediately following the Offer Acceptance Time;
and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">WHEREAS, concurrently with the execution and delivery of this Agreement, and as a condition and inducement to Parent and Purchaser
entering into this Agreement, certain holders of the Company Shares have entered into tender and support agreements, dated as of the Agreement Date, in substantially the form set forth in <U>Annex II</U>, pursuant to which, among other things, each
such holder has agreed to tender his, her or its Company Shares to Purchaser in the Offer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE OFFER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>The Offer</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Commencement of the Offer</U>. Provided that this Agreement shall not have been terminated in accordance with
<U>Section</U><U></U><U>&nbsp;7.01</U>, on January&nbsp;10, 2018, or as promptly thereafter as practicable, but in no event later than January&nbsp;16, 2018, Purchaser shall (and Parent shall cause Purchaser to) commence (within the meaning of
Rule&nbsp;14d <FONT STYLE="white-space:nowrap">-2</FONT> under the Exchange Act) the Offer to Purchase all of the outstanding Company Shares at a price per Company Share equal to the Offer Price, net to the seller in cash, without interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Terms and Conditions of the Offer</U>. The obligations of Purchaser to, and of Parent to cause Purchaser to,
accept for payment, and pay for, any Company Shares validly tendered (and not withdrawn) pursuant to the Offer are subject only to the terms and conditions of this Agreement, including the prior satisfaction of the Minimum Condition and the
satisfaction or, to the extent waivable by Purchaser or Parent, waiver of the other conditions set forth in Annex&nbsp;I (collectively, the &#147;<U>Offer Conditions</U>&#148;). The Offer shall be made by means of an offer to purchase (the
&#147;<U>Offer to Purchase</U>&#148;) that contains the terms set forth in this Agreement, including the Minimum Condition and the other Offer Conditions. Purchaser expressly reserves the right to (i)&nbsp;increase the Offer Price, (ii)&nbsp;waive
any Offer Condition and (iii)&nbsp;make any other changes in the terms and conditions of the Offer not inconsistent with the terms of this Agreement; provided, however, that notwithstanding anything to the contrary contained in this Agreement,
without the prior written consent of the Company, Parent and Purchaser shall not (A)&nbsp;decrease the Offer Price, (B)&nbsp;change the form of consideration payable in the Offer, (C)&nbsp;decrease the maximum number of Company Shares sought to be
purchased in the Offer, (D)&nbsp;impose conditions or requirements to the Offer in addition to the Offer Conditions, (E)&nbsp;amend, change or modify any of the Offer Conditions in a manner that adversely affects, or reasonably could adversely
affect, any holder of Company Shares (collectively, the &#147;<U>Company Stockholders</U>&#148;), (F)&nbsp;amend, change, modify or waive the Minimum Condition or the Offer Conditions set forth in clauses&nbsp;(d), (g)&nbsp;or (h)&nbsp;in Annex I,
or (G)&nbsp;except as provided in <U>Section</U><U></U><U>&nbsp;1.01(c)</U> or <U>Section</U><U></U><U>&nbsp;1.01(d)</U>, terminate or withdraw the Offer or accelerate, extend or otherwise change the Expiration Date. The Offer may not be withdrawn
prior to the Expiration Date (or any rescheduled Expiration Date) of the Offer, unless this Agreement is terminated in accordance with <U>Section</U><U></U><U>&nbsp;7.01</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Expiration and Extension of the Offer</U>. The Offer shall initially be scheduled to expire at 11:59&nbsp;p.m.
Eastern Time on the twentieth (20th)&nbsp;Business Day following the Offer Commencement Date, determined as set forth in <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-1(g)(3)</FONT> and <FONT STYLE="white-space:nowrap">Rule&nbsp;14e-1(a)</FONT>
promulgated under the Exchange Act (unless otherwise agreed to in writing by Parent and the Company) (the &#147;<U>Initial Expiration Date</U>,&#148; such date or such subsequent date and time to which the expiration of the Offer is extended in
accordance with the terms of this Agreement, the &#147;<U>Expiration Date</U>&#148;). Notwithstanding anything to the contrary contained in this Agreement, but subject to the Parties&#146; respective termination rights under
<U>Section</U><U></U><U>&nbsp;7.01</U>: (i)&nbsp;if, as of the scheduled Expiration Date, any Offer Condition is not satisfied and has not been waived, Purchaser shall extend the Offer on one or more occasions, for an additional period of up to ten
(10)&nbsp;Business Days per extension, to permit such Offer Condition to be satisfied; and (ii)&nbsp;Purchaser shall extend the Offer from time to time for any period required by any Law, any rule or regulation of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the SEC or NASDAQ applicable to the Offer; provided, however, that in no event shall Purchaser: (1)&nbsp;be required to extend the Offer beyond the earlier to occur of (the &#147;<U>Extension
Deadline</U>&#148;) (x)&nbsp;the valid termination of this Agreement in compliance with <U>Section</U><U></U><U>&nbsp;7.01</U> and (y)&nbsp;the Outside Date; or (2)&nbsp;be permitted to extend the Offer beyond the Extension Deadline without the
prior written consent of the Company. Purchaser shall not terminate the Offer, or permit the Offer to expire, prior to any scheduled Expiration Date without the prior written consent of the Company except in the event that this Agreement is
terminated pursuant to <U>Section</U><U></U><U>&nbsp;7.01</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination of Offer</U>. In the event that
this Agreement is validly terminated pursuant to <U>Section</U><U></U><U>&nbsp;7.01</U>, Purchaser shall, and Parent shall cause Purchaser to, immediately, irrevocably and unconditionally terminate the Offer and shall not acquire any Company Shares
pursuant to the Offer. If the Offer is terminated or withdrawn by Purchaser in accordance with the terms hereof, Purchaser shall immediately return, and shall cause any depository acting on behalf of Purchaser to return, in accordance with
applicable Laws, all tendered Company Shares to the registered holders thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Offer Documents</U>. As
promptly as practicable on the Offer Commencement Date, Parent and Purchaser shall (i)&nbsp;file with the SEC a tender offer statement on Schedule&nbsp;TO with respect to the Offer (together with all amendments and supplements thereto and including
exhibits thereto, the &#147;<U>Schedule</U><U></U><U>&nbsp;TO</U>&#148;) that, subject to <U>Section</U><U></U><U>&nbsp;5.02(f)</U>, will contain or incorporate by reference the Offer to Purchase and form of the related letter of transmittal and
(ii)&nbsp;cause the Offer to Purchase and related documents to be disseminated to holders of Company Shares. Parent and Purchaser agree that they shall cause the Schedule&nbsp;TO and all exhibits, amendments or supplements thereto (which together
constitute the &#147;<U>Offer Documents</U>&#148;) filed by either Parent or Purchaser with the SEC (x)&nbsp;to comply in all material respects with the Exchange Act and the rules and regulations thereunder and other applicable Laws and (y)&nbsp;to
not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading;
provided, however, that no covenant is made by Parent or Purchaser with respect to information supplied by or on behalf of the Company for inclusion or incorporation by reference in the Offer Documents. Each of Parent, Purchaser and the Company
agrees to promptly correct any information provided by it for use in the Offer Documents if and to the extent that such information shall have become false or misleading in any material respect, and Parent further agrees to take all steps necessary
to cause the Offer Documents as so corrected to be filed with the SEC and to be disseminated to holders of Company Shares, in each case as and to the extent required by applicable federal securities laws. The Company shall promptly furnish or
otherwise make available to Parent and Purchaser or Parent&#146;s legal counsel all information concerning the Company and the Company Stockholders that may be required in connection with any action contemplated by this
<U>Section</U><U></U><U>&nbsp;1.01(e)</U>. The Company and its counsel shall be given reasonable opportunity to review and comment on the Offer Documents (including any response to any comments (including oral comments) of the SEC or its staff with
respect thereto) prior to the filing thereof with the SEC, and Parent and Purchaser shall give reasonable and good faith consideration to any such comments made by the Company or its counsel. Parent and Purchaser agree to provide the Company and its
counsel with any comments that Parent, Purchaser or their counsel may receive from the SEC or its staff with respect to the Offer Documents promptly after receipt of such comments (including oral comments). Each of Parent and Purchaser shall respond
promptly to any comments (including oral comments) of the SEC or its staff with respect to the Offer Documents or the Offer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Funds</U>. Parent shall deposit, or shall cause to be deposited
with the Paying Agent, concurrently with or promptly following the Offer Acceptance Time, all of the funds necessary to purchase all Company Shares that Purchaser becomes obligated to purchase pursuant to <U>Section</U><U></U><U>&nbsp;1.01(b)</U>,
and shall cause Purchaser to perform, on a timely basis, all of Purchaser&#146;s obligations under this Agreement. Parent and Purchaser shall, and each of Parent and Purchaser shall ensure that all of their respective Affiliates shall, tender any
Company Shares held by them into the Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments</U>. If, between the Agreement Date and the Offer
Acceptance Time, the outstanding Company Shares are changed into a different number or class of shares by reason of any stock split, division or subdivision of shares, stock dividend, reverse stock split, consolidation of shares, reclassification,
recapitalization or other similar transaction, then the Offer Price shall be appropriately adjusted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;<U>Acceptance</U>. Subject only to the satisfaction or, to the extent waivable by Purchaser or Parent, waiver by
Purchaser or Parent of each of the Offer Conditions, Purchaser shall, and Parent shall cause Purchaser to, (i)&nbsp;promptly after (and in any event no later than the first (1st)&nbsp;Business Day after) the Expiration Date (ii)&nbsp;accept for
payment all Company Shares validly tendered (and not withdrawn) pursuant to the Offer and (iii)&nbsp;promptly after (and in any event no later than the third (3rd)&nbsp;Business Day after) the Expiration Date pay for such Company Shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.02.&nbsp;&nbsp;&nbsp;&nbsp;<U>Company Actions</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Schedule</U><U></U><U><FONT STYLE="white-space:nowrap">&nbsp;14D-9</FONT></U>. As promptly as practicable on the
day that the Offer is commenced, following the filing of the Schedule&nbsp;TO, the Company shall file with the SEC and disseminate to holders of Company Shares, in each case as and to the extent required by applicable federal securities Laws and
Section&nbsp;262 of the DGCL, a Tender Offer Solicitation/Recommendation Statement on <FONT STYLE="white-space:nowrap">Schedule&nbsp;14D-9</FONT> (together with any exhibits, amendments or supplements thereto, the &#147;<U>Schedule</U><U></U><U><FONT
STYLE="white-space:nowrap">&nbsp;14D-9</FONT></U>&#148;) that, subject to <U>Section</U><U></U><U>&nbsp;5.02(f)</U> shall reflect the Company Board Recommendation and include a notice of appraisal rights in accordance with Section&nbsp;262 of the
DGCL. Prior to such filing and dissemination, the Company shall set the Stockholder List Date as the record date for the purpose of receiving the notice required by Section&nbsp;262(d)(2) of the DGCL. The Company agrees that it will cause the <FONT
STYLE="white-space:nowrap">Schedule&nbsp;14D-9</FONT> to (i)&nbsp;comply in all material respects with the Exchange Act and other applicable Laws and for the notice to comply with Section&nbsp;262 of the DGCL and (ii)&nbsp;to not contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading; provided, however, that no
covenant is made by the Company with respect to information supplied by or on behalf of Parent or Purchaser for inclusion or incorporation by reference in the <FONT STYLE="white-space:nowrap">Schedule&nbsp;14D-9.</FONT> The Company agrees to provide
Parent and its counsel with any comments the Company or its counsel may receive from the SEC or its staff with respect to the <FONT STYLE="white-space:nowrap">Schedule&nbsp;14D-9</FONT> promptly after receipt of such comments. Each of Parent,
Purchaser and the Company agrees to respond promptly to any comments of the SEC or its staff </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and to promptly correct any information provided by it for use in the <FONT STYLE="white-space:nowrap">Schedule&nbsp;14D-9</FONT> if and to the extent that such information shall have become
false or misleading in any material respect, and the Company further agrees to take all steps necessary to cause the <FONT STYLE="white-space:nowrap">Schedule&nbsp;14D-9</FONT> as so corrected to be filed with the SEC and to be disseminated to
holders of Company Shares, in each case as and to the extent required by applicable federal securities laws. Parent and its counsel shall be given reasonable opportunity to review and comment on the
<FONT STYLE="white-space:nowrap">Schedule&nbsp;14D-9</FONT> and any amendment thereto prior to the filing thereof with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Stockholder Lists</U>. As requested by Parent or its agents, the Company shall promptly furnish Parent with a
list of its stockholders, mailing labels and any available listing or computer file containing the names and addresses of all record holders of Company Shares and lists of securities positions of Company Shares held in stock depositories, in each
case accurate and complete as of the most recent practicable date, and shall provide to Parent such additional information (including updated lists of stockholders, mailing labels and lists of securities positions) and such other assistance as
Parent may reasonably request in connection with the Offer and the Merger. The date of the list used to determine the Persons to whom the Offer Documents and <FONT STYLE="white-space:nowrap">Schedule&nbsp;14D-9</FONT> are first disseminated is
referred to in this Agreement as the &#147;<U>Stockholder List Date</U>.&#148; Parent and Purchaser and their agents shall hold in confidence the information contained in any such labels, listings and files, shall use such information only in
connection with the Offer and the Merger and, if this Agreement shall be terminated, shall, upon request by the Company, deliver, and shall use their reasonable efforts to cause their agents to deliver, to the Company (or destroy) all copies and any
extracts or summaries from such information then in their possession or control and, if requested by the Company, promptly certify to the Company in writing that all such material has been returned or destroyed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.03.&nbsp;&nbsp;&nbsp;&nbsp;<U>Merger of Purchaser into the Company</U>. Upon the terms and subject to the conditions set forth
in this Agreement and in accordance with the relevant provisions of the General Corporation Law of the State of Delaware (the &#147; <U>DGCL</U>&#148;), at the Effective Time, Purchaser shall be merged with and into the Company (the
&#147;<U>Merger</U>&#148;). Following the Merger, the separate corporate existence of Purchaser shall cease, and the Company shall continue as the surviving corporation in the Merger (the &#147;<U>Surviving Corporation</U>&#148;) under the name
&#147;Ignyta, Inc.&#148; as a wholly owned Subsidiary of Parent. The Merger will be governed by Section&nbsp;251(h) of the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.04.&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing</U>. The closing of the Merger (the &#147;<U>Closing</U>&#148;) shall occur on the same
date as the Offer Acceptance Time and immediately following the Offer Acceptance Time, unless the conditions set forth in <U>Article VI</U> shall not have not been satisfied or waived by such date (other than those conditions that by their nature
are to be satisfied at the Closing, but subject to their satisfaction or, to the extent permitted by applicable Law and this Agreement, waiver of those conditions), in which case on the date no later than the first (1st) Business Day on which the
conditions set forth in <U>Article VI</U> are satisfied or waived, at the offices of Latham&nbsp;&amp; Watkins LLP, 12670 High Bluff Drive, San Diego, California 92130. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.05.&nbsp;&nbsp;&nbsp;&nbsp;<U>Effective Time</U>. Upon the terms and subject to the conditions set forth herein, concurrently
with the Closing, the parties shall cause the Merger to be consummated by filing with the Secretary of State of the State of Delaware a duly executed certificate of merger as required by the DGCL (the &#147;<U>Certificate of Merger</U>&#148;). The
Merger shall become effective at </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such time as the Certificate of Merger is duly filed with the Secretary of State of the State of Delaware or at such other time as Parent and the Company shall agree in writing and shall specify
in the Certificate of Merger (the time the Merger becomes effective in accordance with the DGCL is referred to as the &#147;<U>Effective Time</U>&#148; and the date on which the Closing occurs is referred to as the &#147;<U>Closing Date</U>&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.06.&nbsp;&nbsp;&nbsp;&nbsp;<U>Effects of the Merger</U>. The Merger shall have the effects set forth herein, the
Certificate of Merger and in the applicable provisions of the DGCL. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time, all the property, rights, privileges, powers and franchises of the Company shall
continue, and those of the Purchaser shall vest, in the Surviving Corporation, and all debts, liabilities and duties of the Company shall remain, and those of Purchaser shall become, the debts, liabilities and duties of the Surviving Corporation.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.07.&nbsp;&nbsp;&nbsp;&nbsp;<U>Certificate of Incorporation and Bylaws</U>. At the Effective Time, the certificate of
incorporation of the Surviving Corporation shall be amended and restated in its entirety to read as the certificate of incorporation of Purchaser in effect immediately prior to the Effective Time (which shall comply with
<U>Section</U><U></U><U>&nbsp;5.06(a)</U>), except that Article FIRST thereof shall read as follows: &#147;The name of the Corporation is Ignyta, Inc.,&#148; and, as so amended, shall be the certificate of incorporation of the Surviving Corporation
until thereafter amended as permitted by Law and this Agreement. At the Effective Time, and without any further action on the part of the Company and Purchaser, the bylaws of the Company shall be amended so that they read in their entirety as the
bylaws of Purchaser as in effect immediately prior to the Effective Time (which shall comply with <U>Section</U><U></U><U>&nbsp;5.06(a)</U>), except that all references therein to Purchaser shall be automatically amended and shall become references
to the Surviving Corporation, and, as so amended, shall be the bylaws of the Surviving Corporation until thereafter amended in accordance with their terms, the certificate of incorporation of the Surviving Corporation and as provided by applicable
Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.08.&nbsp;&nbsp;&nbsp;&nbsp;<U>Directors and Officers</U>. The directors and officers of Purchaser immediately prior
to the Effective Time shall be the directors and officers, respectively, of the Surviving Corporation until their respective death, permanent disability, resignation or removal or until their respective successors are duly elected and qualified.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EFFECT ON THE CAPITAL STOCK OF THE CONSTITUENT CORPORATIONS; EXCHANGE OF CERTIFICATES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>Treatment and Conversion of Shares</U>. At the Effective Time, by virtue of the Merger and
without any action on the part of the Company, Parent, Purchaser or the holders of any shares of capital stock of the Company, Parent or Purchaser: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Each share of Common Stock of the Company (each, a &#147;<U>Share</U>&#148;), issued and outstanding immediately
prior to the Effective Time (other than any Excluded Shares or Dissenting Shares, which, with respect to the Dissenting Shares, shall have only those rights set forth in <U>Section</U><U></U><U>&nbsp;2.07</U>) shall be converted automatically into
and shall thereafter represent the right to receive the Offer Price, in cash, without interest, and subject to any deduction for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
withholding Taxes required by applicable Law in accordance with <U>Section</U><U></U><U>&nbsp;2.05</U> (the &#147;<U>Merger Consideration</U>&#148;). As of the Effective Time, all such Shares
shall no longer be outstanding, shall automatically be canceled and shall cease to exist, and shall thereafter only represent the right to receive the Merger Consideration, if any, to be paid in accordance with
<U>Section</U><U></U><U>&nbsp;2.04</U>, without interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each Share held in the treasury of the Company or
owned, directly or indirectly, by Parent or Purchaser immediately prior to the Effective Time (collectively, &#147;<U>Excluded Shares</U>&#148;) shall automatically be cancelled and shall cease to exist, and no consideration shall be delivered in
exchange therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Each share of common stock, par value $0.01 per share, of Purchaser issued and outstanding
immediately prior to the Effective Time shall be converted into and become one validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> share of common stock, par value $0.01 per share, of the Surviving Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02.&nbsp;&nbsp;&nbsp;&nbsp;<U>Treatment of Company Warrants</U>. Prior to the Effective Time, the Company shall, in accordance
with the terms of all unexercised and unexpired warrants to purchase Shares under any warrant agreements entered into by the Company and the warrant holders party thereto (collectively, the &#147;<U>Company Warrants</U>&#148;), deliver notices to
the holders of the Company Warrants, informing such holders of the Merger and containing such other information as the Company reasonably determines to be required pursuant to the terms of the Company Warrants. At the Effective Time, each Company
Warrant, whether vested or unvested and exercisable or unexercisable, that is issued, outstanding and unexercised immediately prior to the Effective Time, and not terminated pursuant to its terms in connection with the Merger, shall thereupon
represent the right to receive, in exchange for the surrender and cancellation therefor, an amount in cash (without interest and subject to any deduction for withholding Taxes required by applicable Law in accordance with
<U>Section</U><U></U><U>&nbsp;2.05</U>) to be paid to each former holder of any such cancelled Company Warrant equal to the product, if any, of (i)&nbsp;the number of Shares subject to such Company Warrant and (ii)&nbsp;the excess, if any, of the
Merger Consideration over the exercise price per Share under such Company Warrant (the &#147;<U>Warrant Consideration</U>&#148;); <U>provided</U> that, if the exercise price per Share of any such Company Warrant is equal to or greater than the
Merger Consideration, such Company Warrant shall be cancelled without any payment being made in respect thereof. Upon the surrender and cancellation of each Company Warrant in accordance with this <U>Section</U><U></U><U>&nbsp;2.02</U>, each former
holder of such cancelled Company Warrant shall cease to have any rights with respect thereto, except the right to receive from the Surviving Corporation the Warrant Consideration payable with respect thereto pursuant to this
<U>Section</U><U></U><U>&nbsp;2.02</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.03.&nbsp;&nbsp;&nbsp;&nbsp;<U>Treatment of Company Options and Restricted Stock
Units</U>. At the Effective Time: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Each option to purchase Shares (each, a &#147;<U>Company Option</U>&#148;)
granted pursuant to any of the Company&#146;s Amended and Restated 2011 Equity Incentive Award Plan, the Company&#146;s Amended and Restated 2014 Equity Incentive Award Plan, the Company&#146;s Employment Inducement Incentive Award Plan, the
Company&#146;s 2015 Employment Inducement Incentive Award Plan, the Company&#146;s 2017 Employment Inducement Incentive Award Plan, or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any other plan, agreement or arrangement (together, the &#147;<U>Company Stock Plans</U>&#148;), whether vested or unvested, that is outstanding immediately prior to the Effective Time, shall
automatically (i)&nbsp;be accelerated and vest in full, (ii)&nbsp;be cancelled and terminated as of the Effective Time (to the extent not exercised prior to the Effective Time), and, in exchange therefor, the Surviving Corporation shall pay, through
its payroll system by the later of (x)&nbsp;five (5)&nbsp;days following the Effective Time and (y)&nbsp;the first payroll date after the Effective Time, to each former holder of any such cancelled Company Option an amount in cash (without interest,
and subject to deduction for any required withholding Taxes in accordance with <U>Section</U><U></U><U>&nbsp;2.05</U>) equal to the product of (A)&nbsp;the number of Shares subject to such Company Option <U>multiplied by</U> (B)&nbsp;the excess, if
any, of the Merger Consideration over the exercise price per Share under such Company Option (the &#147;<U>Option Consideration</U>&#148;); <U>provided</U> that, if the exercise price per Share of any such Company Option is equal to or greater than
the Merger Consideration, then such Company Option shall be cancelled without any cash payment being made in respect thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each restricted stock unit awarded pursuant to any Company Stock Plan (each, a &#147;<U>Restricted Stock
Unit</U>&#148;), whether vested or unvested, that is outstanding immediately prior to the Effective Time, (i)&nbsp;shall automatically be fully accelerated and vest in full, (ii)&nbsp;the restrictions thereon shall lapse, and (iii)&nbsp;shall be
cancelled and terminated as of the Effective Time, and, in exchange therefor, the Surviving Corporation shall pay, through its payroll system by the later of (x)&nbsp;five (5)&nbsp;days following the Effective Time and (y)&nbsp;the first payroll
date after the Effective Time, to each former holder of any such cancelled Restricted Stock Unit an amount in cash (without interest, and subject to deduction for any required withholding Taxes in accordance with
<U>Section</U><U></U><U>&nbsp;2.05</U>) equal to the Merger Consideration (the &#147;<U>RSU Consideration</U>&#148;) on the terms and conditions set forth in <U>Section</U><U></U><U>&nbsp;2.01</U>, this <U>Section</U><U></U><U>&nbsp;2.03</U> and
<U>Section</U><U></U><U>&nbsp;2.04</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.04.&nbsp;&nbsp;&nbsp;&nbsp;<U>Exchange and Payment</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;On or prior to the Effective Time, (i)&nbsp;Parent will, or will cause to be deposited, with a paying agent, bank or
trust company designated by Parent and reasonably acceptable to the Company (the &#147;<U>Paying Agent</U>&#148;), in trust for the benefit of holders of Shares and Company Warrants immediately prior to the Effective Time (other than holders to the
extent they hold Excluded Shares), cash in an amount sufficient to pay the aggregate Merger Consideration to be paid pursuant to <U>Section</U><U></U><U>&nbsp;2.01</U> and the aggregate Warrant Consideration to be paid pursuant to
<U>Section</U><U></U><U>&nbsp;2.02</U> (which, for the avoidance of doubt, in each case shall not include the Option Consideration or the RSU Consideration) and (ii)&nbsp;Parent will, or will cause to be deposited with the Surviving Corporation,
cash in an amount sufficient to pay the aggregate Option Consideration, if any, and the aggregate RSU Consideration to be paid in accordance with <U>Section</U><U></U><U>&nbsp;2.03</U> (such cash in clauses&nbsp;(i) and (ii), in the aggregate, the
&#147;<U>Payment Fund</U>&#148;). The Payment Fund shall not be used for any purpose other than to fund payments due pursuant to this <U>Article</U><U></U><U>&nbsp;II</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;As soon as reasonably practicable after the Effective Time, the Surviving Corporation shall cause the Paying Agent
to mail to each Person who was the record holder of a certificate (each, a &#147;<U>Certificate</U>&#148;) that immediately prior to the Effective Time represented outstanding Shares that were converted into the right to receive the Merger
Consideration and to each holder of uncertificated Shares represented by book entry (&#147;<U>Book-Entry Shares</U>&#148;): (i)&nbsp;a form of letter of transmittal (which shall specify that delivery shall be effected, and risk of loss
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and title to the Certificates and Book-Entry Shares shall pass, only upon proper delivery of the Certificates or Book-Entry Shares, as applicable, to the Paying Agent, and which shall be in
customary form and contain such other provisions as Parent, the Company or the Paying Agent may reasonably specify) and (ii)&nbsp;instructions for use in effecting the surrender of the Certificates (or affidavits of loss in lieu thereof) or
Book-Entry Shares in exchange for the Merger Consideration. Upon surrender to the Paying Agent of a Certificate (or affidavit of loss in lieu thereof) or Book-Entry Shares, together with such letter of transmittal duly completed and validly executed
in accordance with the instructions thereto, and such other documents as may be reasonably required by the Paying Agent, the holder of such Certificate or Book-Entry Shares shall be entitled to receive in exchange for the Shares formerly represented
by such Certificate or Book-Entry Shares (other than Excluded Shares and Dissenting Shares) the Merger Consideration for each such Share (subject to deduction for any required withholding Taxes), and the Certificate or Book-Entry Shares so
surrendered shall immediately be canceled. No interest will be paid or accrued for the benefit of holders of Certificates or Book-Entry Shares on the Merger Consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;If payment of the Merger Consideration is to be made to a Person other than the Person in whose name the
surrendered Certificate or Book-Entry Share is registered, it shall be a condition of payment that such Certificate so surrendered shall be properly endorsed or shall be otherwise in proper form for transfer or such Book-Entry Share shall be
properly transferred and that the Person requesting such payment shall have paid any transfer and other Taxes required by reason of the payment of the Merger Consideration to a Person other than the registered holder of such Certificate or
Book-Entry Share or shall have established to the satisfaction of Parent that such Tax is not applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Until surrendered in accordance with the provisions of this <U>Section</U><U></U><U>&nbsp;2.04</U>, each
Certificate or Book-Entry Share (other than Certificates and Book-Entry Shares representing any Excluded Shares or Dissenting Shares) shall be deemed after the Effective Time to represent solely the right to receive the Merger Consideration payable
in respect thereof pursuant to this <U>Article</U><U></U><U>&nbsp;II</U>, without any interest thereon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;All
cash paid upon the surrender for exchange of Certificates or Book-Entry Shares in accordance with the terms of this <U>Article</U><U></U><U>&nbsp;II</U> shall be deemed to have been paid in full satisfaction of all rights pertaining to the Shares
formerly represented by such Certificates or Book-Entry Shares. At the Effective Time, the stock transfer books of the Company shall be closed and there shall be no further registration of transfers of the Shares that were outstanding immediately
prior to the Effective Time. If, after the Effective Time, Certificates are presented to the Surviving Corporation or the Paying Agent for transfer or transfer is sought for Book-Entry Shares, such Certificates or Book-Entry Shares shall be
cancelled and exchanged as provided in this <U>Article</U><U></U><U>&nbsp;II</U>, subject to applicable Law in the case of Dissenting Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;The Paying Agent shall invest any cash remaining in the Payment Fund as directed by Parent, on a daily basis,
<U>provided</U>, that (i)&nbsp;no such investment or losses thereon shall affect the Merger Consideration payable to the holders of Shares and the Warrant Consideration payable to holders of Company Warrants, (ii)&nbsp;following any such losses or
events that result in the Payment Fund becoming not immediately available or that result in the amount of funds in the Payment Fund being insufficient to promptly pay the portion of the aggregate Merger
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Consideration and the portion of the aggregate Warrant Consideration that remains unpaid, Parent shall promptly provide additional funds to the Paying Agent for the benefit of the holders of
Shares and Company Warrants to the extent of such insufficiency and (iii)&nbsp;such investments shall be in obligations of or guaranteed by the United States of America or in commercial paper obligations rated
<FONT STYLE="white-space:nowrap">P-1</FONT> or <FONT STYLE="white-space:nowrap">A-1</FONT> or better by Moody&#146;s Investor Services, Inc. or Standard&nbsp;&amp; Poor&#146;s Corporation, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Any portion of the Payment Fund (and any interest or other income earned thereon) that remains undistributed to the
holders of Certificates, Book-Entry Shares or Company Warrants one (1)&nbsp;year after the Effective Time shall be delivered to Parent, upon demand, and any remaining holders of Certificates, Book-Entry Shares or Company Warrants (except to the
extent representing Excluded Shares or Dissenting Shares) shall thereafter look only to Parent as general creditors thereof for payment of the Merger Consideration and Warrant Consideration (subject to abandoned property, escheat or other similar
laws), without interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;None of Parent, Purchaser, the Surviving Corporation or the Paying Agent shall be
liable to any holder of Shares or Company Warrants for any amounts (whether in respect of such Shares or Company Warrants or otherwise) delivered from the Payment Fund or otherwise to a public official pursuant to any applicable abandoned property,
escheat or similar Law. If any Certificates or Book-Entry Shares shall not have been exchanged prior to two (2)&nbsp;years after the Effective Time (or immediately prior to such earlier date on which the related Merger Consideration or Warrant
Consideration would otherwise escheat to or become the property of any Governmental Entity), any such Merger Consideration or Warrant Consideration in respect thereof shall, to the extent permitted by applicable Law, become the property of Parent,
free and clear of all claims or interest of any Person previously entitled thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;If any Certificate shall
have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed and, if required by Parent or the Paying Agent, the posting by such person of a bond in such
amount as Parent or the Paying Agent may determine is reasonably necessary or, if required by Parent or the Paying Agent, agreeing to provide indemnity against any claim that may be made against the Paying Agent or the Surviving Corporation with
respect to such Certificate, the Paying Agent will deliver to such Person in exchange for such lost, stolen or destroyed Certificate the Merger Consideration payable in respect thereof pursuant to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Any portion of the Payment Fund made available to the Paying Agent pursuant to
<U>Section</U><U></U><U>&nbsp;2.01(a)</U> to pay for Shares for which appraisal rights have been perfected as described in <U>Section</U><U></U><U>&nbsp;2.07</U> shall be returned to Parent, upon demand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.05.&nbsp;&nbsp;&nbsp;&nbsp;<U>Withholding Taxes</U>. Each of the Company, Parent, the Purchaser, the Surviving Corporation and
the Paying Agent shall be entitled to deduct and withhold from the consideration, otherwise payable pursuant to this Agreement or otherwise, such amounts as are required to be deducted or withheld under the Internal Revenue Code of 1986, as amended
(the &#147;<U>Code</U>&#148;) or the Treasury Regulations promulgated thereunder, or any applicable provision of state, local or foreign Tax Law. To the extent that amounts are so deducted and/or withheld, such amounts shall be treated for all
purposes of this Agreement as having been paid to the Person in respect of which such deduction and/or withholding was made. Parent, the Surviving Corporation or the Paying Agent, as the case may be, shall timely remit to the appropriate
Governmental Entity any and all amounts so deducted or withheld. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.06.&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments to Prevent Dilution</U>. If at any time
during the period between the date of this Agreement and the Effective Time, any change in the outstanding shares of capital stock of the Company, or securities convertible into or exchangeable into or exercisable for shares of such capital stock,
shall occur as a result of any reclassification, recapitalization, stock split (including a reverse stock split) or subdivision or combination, exchange or readjustment of shares, or any stock dividend or stock distribution with a record date during
such period, merger or other similar transaction, the Merger Consideration, Warrant Consideration, Option Consideration and RSU Consideration shall be equitably adjusted so as to provide Parent and the holder of Shares the same economic effect as
contemplated by this Agreement prior to such event; <U>provided</U>, that in any case, nothing in this <U>Section</U><U></U><U>&nbsp;2.06</U> shall be construed to permit the Company to take any action that is prohibited by the terms of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.07.&nbsp;&nbsp;&nbsp;&nbsp;<U>Dissenting Shares</U>. Notwithstanding anything in this Agreement to the
contrary, Shares issued and outstanding immediately prior to the Effective Time that are held by any holder who has not voted in favor of the Merger and who properly demands appraisal of such Shares pursuant to Section&nbsp;262 of the DGCL (the
&#147;<U>Dissenting Shares</U>&#148;) shall not be converted into the right to receive the Merger Consideration, but shall be converted into the right to receive such consideration as may be determined to be due to the holders of Dissenting Shares
pursuant to the DGCL, unless and until such holders shall have failed to perfect or shall have effectively withdrawn or lost, such holder&#146;s right to appraisal under the DGCL. Dissenting Shares shall be treated in accordance with
Section&nbsp;262 of the DGCL. If any such holder fails to perfect or withdraws or loses any such right to appraisal, each such Share of such holder shall thereupon be converted into and become exchangeable only for the right to receive, as of the
later of the Effective Time and the time that such right to appraisal has been irrevocably lost, withdrawn or expired, the Merger Consideration in accordance with <U>Section</U><U></U><U>&nbsp;2.01(a)</U>. The Company shall give Parent prompt notice
of any written demands for appraisal of any Shares, withdrawals of such demands and any other instruments served pursuant to the DGCL and received by the Company relating to rights to be paid the &#147;fair value&#148; of Dissenting Shares, as
provided in Section&nbsp;262 of the DGCL, and Parent shall have the right to participate in all negotiations and proceedings with respect to such demands. The Company shall not, except with the prior written consent of Parent, voluntarily make or
agree to make any payment with respect to any demands for appraisals of capital stock of the Company, offer to settle or settle any such demands or approve any withdrawal of any such demands. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.08.&nbsp;&nbsp;&nbsp;&nbsp;<U>Loan Payoff</U>. Prior to the Closing, the Company shall satisfy all notification and consent
requirements, as applicable, under the terms of the Loan Agreement. No less than five business days prior to the Closing Date, the Company shall obtain a customary payoff letter signed by each lender under the Loan Agreement (the &#147;<U>Payoff
Letter</U>&#148;) for the Loan Agreement, which Payoff Letter shall provide (a)&nbsp;the dollar amount of all indebtedness, all accrued but unpaid interest and all fees and expenses required to be paid under the Loan Agreement in order to fully and
finally pay off all obligations under the Loan Agreement as of the Closing (the &#147;<U>Payoff Amount</U>&#148;), (b)&nbsp;that upon receipt of the Payoff Amount, the Loan Agreement and all related instruments evidencing the obligations thereunder
shall be terminated or fully satisfied and discharged, (c)&nbsp;that guarantees, if any, securing such borrowings or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obligations under the Loan Agreement shall be, upon the payment of the Payoff Amount on the Closing Date, released and terminated and (d)&nbsp;upon the payment of the Payoff Amount on the Closing
Date, that the Liens under the Loan Agreement are released and the Company shall be authorized to make all appropriate termination filings to effect such release and termination. Parent shall pay or cause to be paid the Payoff Amount in full on the
Closing Date on behalf of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.09.&nbsp;&nbsp;&nbsp;&nbsp;<U>Further Action</U>. If, at any time after the
Effective Time, any further action is reasonably determined by Parent to be necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Corporation with full right, title and possession of and to all rights and
property of Purchaser and the Company, the officers and directors of the Surviving Corporation and Parent shall be fully authorized (in the name of Purchaser, in the name of the Company and otherwise) to take such action. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;III </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Except (i)&nbsp;as set forth in the corresponding section or subsection of the disclosure letter delivered by the Company to Parent
immediately prior to or concurrently with the execution of this Agreement (the &#147;<U>Disclosure Letter</U>&#148;) (it being agreed that the disclosure of any information in a particular section or subsection of the Disclosure Letter shall be
deemed disclosure of such information with respect to any other section or subsection of this Agreement to which the relevance of such information is readily apparent on its face and that any update of or modification to the Company Disclosure
Letter made or purported to have been made after the date of the Agreement shall be disregarded) or (ii)&nbsp;as disclosed in the reports, schedules, forms, statements and other documents filed by the Company with the Securities and Exchange
Commission (the &#147;<U>SEC</U>&#148;) or furnished by the Company to the SEC and publicly available, in each case, since January&nbsp;1, 2016 (excluding any disclosures set forth in any such Company SEC document in any risk factor section, any
disclosure in any section relating to forward-looking statements or any other statements that are <FONT STYLE="white-space:nowrap">non-specific,</FONT> predictive or primarily cautionary in nature but for purposes of clarification, including and
giving effect to any factual or historical statements included in any such statements) where the relevance of the information as an exception to (or disclosure for purposes of) a particular representation is readily apparent on the face of such
disclosure, the Company represents and warrants to Parent and Purchaser as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization and Qualification</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company is a duly organized and validly existing corporation in good standing under the DGCL, with all corporate
power and authority to own, lease and operate its properties and assets and to conduct its business as currently conducted. The Company is duly qualified and in good standing as a foreign corporation authorized to do business in each of the
jurisdictions in which the character of the properties owned or held under lease by it or the nature of the business transacted by it makes such qualification necessary, except to the extent the failure to be so qualified or in good standing has not
resulted and would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect. The Company has heretofore made available to Parent true, correct and complete copies of the Company&#146;s
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
certificate of incorporation and bylaws as currently in effect, which certificate of incorporation and bylaws are all in full force and effect. The Company is not in material violation of any of
the provisions of its certificate of incorporation or bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company does not, directly or indirectly,
own any equity, membership interest, partnership interest, joint venture interest, or other equity or voting interest in, or any interest convertible into, exercisable or exchangeable for any of the foregoing, nor is the Company under any current or
prospective obligation to provide funds to, make any loan, capital contribution, guarantee, credit enhancement or other investment in, or assume any liability or obligation of, any Person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02.&nbsp;&nbsp;&nbsp;&nbsp;<U>Capitalization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The authorized capital stock of the Company consists of 150,000,000 shares of common stock, par value $0.0001 per
share (&#147;<U>Common Stock</U>&#148;), and 10,000,000 shares of preferred stock, par value $0.0001 per share (&#147;<U>Preferred Stock</U>&#148;). At the close of business on December&nbsp;21, 2017 (the &#147;<U>Measurement Date</U>&#148;),
(a)&nbsp;67,591,938 shares of Common Stock were issued and 67,588,990 shares of Common Stock were outstanding, (b)&nbsp;no shares of Preferred Stock were issued and outstanding, (c)&nbsp;an aggregate of 2,948 shares of Common Stock were held by the
Company in its treasury, (d)&nbsp;an aggregate of 5,701,819 shares of Common Stock were reserved for issuance pursuant to outstanding awards and rights under the Company Stock Plans, of which 5,470,299 shares of Common Stock were underlying
outstanding and unexercised Company Options and 231,520 shares of Common Stock were underlying unvested Restricted Stock Units and (e)&nbsp;an aggregate of 98,698 shares of Common Stock were reserved for issuance pursuant to outstanding Company
Warrants. Except for changes since the close of business on the Measurement Date resulting from the exercise of Company Options, the vesting of Restricted Stock Units or the exercise of the Company Warrants, from the Measurement Date until the date
hereof, the Company has not issued any shares of its capital stock, has not granted any options, restricted stock, restricted stock units, stock appreciation rights, warrants or rights or entered into any other agreements or commitments to issue any
shares of its capital stock, or granted any other awards in respect of any shares of its capital stock and has not split, combined or reclassified any of its shares of capital stock. All of the outstanding Shares have been, and all shares of Common
Stock reserved for issuance as noted in (d)&nbsp;and (e) above will be, when issued in accordance with the terms thereof, duly authorized and validly issued, fully paid and nonassessable and free of preemptive rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section</U><U></U><U>&nbsp;3.02</U> of the Disclosure Letter contains a true, correct and complete list, as of
the close of business of the Measurement Date, of (i)&nbsp;the name of each holder of Company Options and Restricted Stock Units, the type and number of outstanding Company Options and Restricted Stock Units held by such holder, the grant date of
each such Company Option and Restricted Stock Unit, the number of Shares such holder is entitled to receive upon the exercise of each Company Option and the corresponding exercise price, the expiration date of each Company Option and the name of the
Company Stock Plan pursuant to which each such Company Option or Restricted Stock Unit was granted, and (ii)&nbsp;the name of each holder of Company Warrants, the number of Shares such holder is entitled to receive upon the exercise of each Company
Warrant and the corresponding exercise price and the expiration date of each Company Warrant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except for the Company Options, the Restricted Stock Units and the
Company Warrants, there are, as of the Measurement Date, no outstanding (w)&nbsp;securities of the Company convertible into or exchangeable for shares of capital stock or voting securities or ownership interests in the Company, (x)&nbsp;options,
warrants, rights or other agreements or commitments requiring the Company to issue, or other obligations of the Company to issue, any capital stock, voting securities or other ownership interests in (or securities convertible into or exchangeable
for capital stock or voting securities or other ownership interests in) the Company (or, in each case, the economic equivalent thereof), (y)&nbsp;obligations of the Company to grant, extend or enter into any subscription, warrant, right, convertible
or exchangeable security or other similar agreement or commitment relating to any capital stock, voting securities or other ownership interests in the Company (the items in clauses&nbsp;(w), (x) and (y), together with the capital stock of the
Company, being referred to collectively as &#147;<U>Company Securities</U>&#148;) or (z)&nbsp;obligations by the Company to make any payments based on the price or value of the Shares. There are, as of the Measurement Date, no outstanding
obligations of the Company to purchase, redeem or otherwise acquire any Company Securities. There are no voting trusts or other agreements or understandings to which the Company is a party with respect to the voting of capital stock of the Company.
All outstanding securities of the Company have been offered and issued in all material respects in compliance with the Securities Act of 1933, as amended (the &#147;<U>Securities Act</U>&#148;). The exercise price of each Company Option is not less
than the fair market value of a Share on the date of grant of such Company Option. No Company Option provides for the deferral of compensation within the meaning of Section&nbsp;409A of the Code. Except as set forth on
<U>Section</U><U></U><U>&nbsp;3.02</U> of the Disclosure Letter, there are no outstanding or authorized equity-based compensation awards with respect to the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03.&nbsp;&nbsp;&nbsp;&nbsp;<U>Authority; Board Action</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company has all requisite corporate power and authority to execute and deliver this Agreement and to perform its
obligations hereunder and consummate the Transactions. The execution and delivery of this Agreement by the Company and the consummation by the Company of the Transactions, including the Offer and the Merger, have been duly, validly and unanimously
authorized by the Company Board and no other corporate proceedings on the part of the Company are necessary to authorize this Agreement or to consummate the Transactions. This Agreement has been duly and validly executed and delivered by the Company
and, assuming the due authorization, execution and delivery by Parent and Purchaser, constitutes a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that enforceability
may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar Laws affecting the enforcement of creditors&#146; rights generally or by general principles of equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company Board, at a meeting or meetings duly called and held, has adopted resolutions (i)&nbsp;determining that
the terms of this Agreement, the Offer, the Merger and the other transactions contemplated hereby are fair to and in the best interests of the Company&#146;s stockholders, (ii)&nbsp;approving and declaring advisable this Agreement and the
transactions contemplated hereby, including the Offer and the Merger, and (iii)&nbsp;resolving to recommend that the Company&#146;s stockholders accept the Offer and tender their Company Shares to Purchaser pursuant to the Offer, which resolutions
have not been subsequently rescinded, modified or withdrawn, except as may be permitted by <U>Section</U><U></U><U>&nbsp;5.02</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.04.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Conflict; Consents and Approvals</U>. Except for
matters that have not resulted and would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect solely with respect to clauses&nbsp;(b) through (e)&nbsp;below, neither the execution and delivery of this
Agreement by the Company nor the consummation of the transactions contemplated hereby will (a)&nbsp;violate or conflict with or result in any breach of any provision of the certificate of incorporation or bylaws of the Company, (b)&nbsp;require any
consent, approval, authorization or permit of, or filing with or notification to, any supranational, national, foreign, federal, state or local government or subdivision thereof, or governmental, judicial, legislative, executive, administrative or
regulatory authority (including the FDA), agency, commission, tribunal or body (a &#147;<U>Governmental Entity</U>&#148;) except (i)&nbsp;as may be required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the &#147;<U>HSR
Act</U>&#148;) and any applicable foreign antitrust or competition Laws (&#147;<U>Foreign Antitrust Laws</U>&#148;), (ii)&nbsp;the applicable requirements of the Securities Exchange Act of 1934, as amended (the &#147;<U>Exchange Act</U>&#148;) and
the rules and regulations promulgated thereunder, (iii)&nbsp;the filing and recordation of appropriate merger documents as required by the DGCL, and (iv)&nbsp;the applicable requirements of the Nasdaq Global Market, (c)&nbsp;violate, conflict with,
or result in a breach of any provisions of, or require any consent, waiver or approval or result in a default (or give rise to any right of termination, cancellation, modification, purchase or repurchase, option exercise, put or call, acceleration
or any event that, with the giving of notice, the passage of time or otherwise, would constitute a default or give rise to any such right) under any of the terms, conditions or provisions of any Contract to which the Company is a party or by which
the Company, or any property or asset of the Company, is bound or affected, (d)&nbsp;result (or, with the giving of notice, the passage of time or otherwise, would result) in the creation or imposition of any mortgage, lien, pledge, charge, security
interest or encumbrance of any kind on any asset of the Company (each, a &#147;<U>Lien</U>&#148;) other than (i)&nbsp;Liens which do not, individually or in the aggregate, materially detract from the value or materially interfere with any present or
intended use of such property or assets (collectively, &#147;<U>Permitted Liens</U>&#148;) or (ii)&nbsp;Liens created by Parent or Purchaser, or (e)&nbsp;violate any order, writ, injunction, decree, statute, rule or regulation applicable to the
Company or by which any of its assets are bound. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.05.&nbsp;&nbsp;&nbsp;&nbsp;<U>SEC Reports; Financial Statements</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Since January&nbsp;1, 2016, the Company has timely filed or furnished all reports, schedules, forms, statements and
other documents required to be filed or furnished by it with or to the SEC, all of which have complied as of their respective filing dates or, if amended or superseded by a subsequent filing, as of the date of the last such amendment or superseding
filing, in all material respects with all applicable requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act of 2002 (the &#147;<U>Sarbanes-Oxley Act</U>&#148;) and, in each case, the rules and regulations of the SEC
promulgated thereunder. No executive officer of the Company has failed in any material respect to make the certifications required of him or her under Section&nbsp;302 or 906 of the Sarbanes-Oxley Act with respect to any Company SEC Report. None of
the reports, schedules, forms, statements and other documents filed with or furnished to the SEC by the Company since January&nbsp;1, 2016, including any financial statements or schedules included or incorporated by reference therein (all such
documents, together with all exhibits and schedules to the foregoing materials and all information incorporated therein by reference, the &#147;<U>Company SEC Reports</U>&#148;), at the time filed or, if amended or superseded by a subsequent filing,
as of the date of the last such amendment or superseding filing, contained any untrue statement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were
made, not misleading. As of the date of this Agreement, there are no outstanding or unresolved comments in comment letters received from the SEC staff with respect to the Company SEC Reports. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The financial statements (including the related notes and schedules thereto) of the Company included (or
incorporated by reference) in the Company SEC Reports (i)&nbsp;have been prepared in accordance with United States generally accepted accounting principles (&#147;<U>GAAP</U>&#148;) (except as may be indicated in the notes thereto) applied on a
consistent basis during the periods involved and fairly present in all material respects the financial position of the Company as of their respective dates, and the income, stockholders equity, results of operations and changes in consolidated
financial position or cash flows for the periods presented therein (subject, in the case of the unaudited financial statements, to the absence of footnotes and normal <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments) and
(ii)&nbsp;comply in all material respects with the applicable accounting requirements and with the rules and regulations of the SEC, the Exchange Act and the Securities Act. As of the date of this Agreement, the Company does not intend to correct in
any material respect or restate, and to the Knowledge of the Company there is not any basis to restate, any of the audited financial statements or unaudited interim financial statements (including, in each case, the notes, if any, thereto) of the
Company filed in or furnished with the Company SEC Reports. No financial statements of any Person other than the Company are required by GAAP to be included in the financial statements of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company has established and maintained disclosure controls and procedures (as defined in <FONT
STYLE="white-space:nowrap">Rule&nbsp;13a-15</FONT> under the Exchange Act). Such disclosure controls and procedures are designed to ensure that material information relating to the Company is made known to the Company&#146;s principal executive
officer and its principal financial officer by others within those entities, particularly during the periods in which the periodic reports required under the Exchange Act are being prepared. Such disclosure controls and procedures are effective in
timely alerting the Company&#146;s principal executive officer and principal financial officer to material information required to be included in the Company&#146;s periodic and current reports required under the Exchange Act. For purposes of this
Agreement, &#147;principal executive officer&#148; and &#147;principal financial officer&#148; shall have the meanings given to such terms in the Sarbanes-Oxley Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company has established and maintained a system of internal control over financial reporting (as defined in <FONT
STYLE="white-space:nowrap">Rule&nbsp;13a-15</FONT> under the Exchange Act) sufficient to provide reasonable assurance regarding the reliability of the Company&#146;s financial reporting and the preparation of Company financial statements for
external purposes in accordance with GAAP. The Company has disclosed, based on its most recent evaluation of internal controls prior to the date hereof, to the Company&#146;s auditors and audit committee (i)&nbsp;any significant deficiencies and
material weaknesses in the design or operation of internal controls which are reasonably likely to adversely affect the Company&#146;s ability to record, process, summarize and report financial information and (ii)&nbsp;any fraud, whether or not
material, that involves management or other employees who have a significant role in internal controls. To the Knowledge of the Company, any material change in internal control over financial reporting required to be disclosed in any Company SEC
Report has been so disclosed. The Company has made available to Parent and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Purchaser (or outside counsel) prior to the date of this Agreement a summary of any such disclosure made by management to the Company&#146;s auditors and audit committee since January&nbsp;1,
2015 through the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Company is not party to, nor has entered into any Contract to become a party
to, any joint venture, <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet partnership or any similar Contract or arrangement (including any Contract relating to any transaction or relationship between or among the Company, on the one hand,
and any unconsolidated Affiliate, including any structured finance, special purpose or limited purpose entity or person, on the other hand, or any <FONT STYLE="white-space:nowrap">&#147;off-balance</FONT> sheet arrangements&#148; (as defined in
Item&nbsp;303(a) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> of the SEC)), where the result, purpose or intended effect of such Contract is to avoid disclosure of any material transaction involving, or material liabilities of, the
Company&#146;s in the Company&#146;s audited financial statements or other Company SEC Reports. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;To the
Knowledge of the Company, none of the Company SEC Reports is the subject of ongoing SEC review and there are no inquiries or investigations by the SEC or any internal investigations pending or threatened, in each case regarding any accounting
practices of the Company. Since January&nbsp;1, 2016, (i)&nbsp;the Company has not received any material written complaint, allegation, assertion or claim regarding the accounting or auditing practices, procedures, methodologies or methods of the
Company or its internal accounting controls relating to periods since January&nbsp;1, 2016, including any credible complaint, allegation, assertion or claim that the Company has engaged in questionable accounting or auditing practices and
(ii)&nbsp;no attorney representing the Company, whether or not employed by the Company, has reported evidence of a material violation of applicable Laws, breach of fiduciary duty or similar violation by the Company or their respective officers,
directors, employees or agents to the Company Board or any committee thereof or, to the Knowledge of the Company, to any director or officer of the Company pursuant to the rules of the SEC adopted under Section&nbsp;307 of the Sarbanes-Oxley Act.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.06.&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence of Certain Changes</U>. Since January&nbsp;1, 2017, (a)&nbsp;the Company has not
suffered any Material Adverse Effect and there has not been any change, condition, event or development that is reasonably likely to result, individually or in the aggregate, in a Material Adverse Effect, (b)&nbsp;the Company has, in all material
respects, conducted its business in the ordinary course of business consistent with past practice, except for the negotiation, execution, delivery and performance of this Agreement and (c)&nbsp;the Company has not undertaken any action that would be
prohibited by <U>Section</U><U></U><U>&nbsp;5.01(c)</U>, <U>(p)</U> and <U>(q)</U>&nbsp;if such sections were in effect at all times since September&nbsp;30, 2017, except for the negotiation, execution, delivery and performance of this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.07.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Undisclosed Material Liabilities</U>. There are no liabilities or obligations of the
Company of any kind whatsoever, whether accrued, contingent, absolute, known, unknown, determined, determinable or otherwise, other than: (i)&nbsp;liabilities or obligations disclosed and reserved for in the balance sheet of the Company as of
September&nbsp;30, 2017 and included in the Company SEC Reports, (ii)&nbsp;liabilities or obligations incurred after September&nbsp;30, 2017 in the ordinary course of business consistent with past practice (excluding liabilities arising out of any
breach of or default under a Contract or violation of applicable Law), (iii)&nbsp;obligations expressly contemplated by, and fees and expenses payable to its external Representatives for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
services rendered in connection with, this Agreement, any other transaction documents and the transactions contemplated hereby and thereby, (iv)&nbsp;liabilities or obligations under Material
Contracts existing as of the date of this Agreement or entered into after the date hereof as permitted under <U>Section</U><U></U><U>&nbsp;5.01</U> of this Agreement (excluding liabilities arising out of any breach or default under such Material
Contracts), and (v)&nbsp;liabilities or obligations that have not resulted and would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.08.&nbsp;&nbsp;&nbsp;&nbsp;<U>Brokers; Certain Expenses</U>. No broker, finder, investment banker or financial advisor (other
than Merrill Lynch, Pierce, Fenner&nbsp;&amp; Smith Incorporated and J.P.&nbsp;Morgan Securities LLC (the &#147;<U>Company Financial Advisors</U>&#148;)) is or shall be entitled to receive any brokerage, finder&#146;s, financial advisor&#146;s,
transaction or other fee or commission in connection with this Agreement or the transactions contemplated hereby based upon agreements made by or on behalf of the Company or any of its officers, directors or employees. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.09.&nbsp;&nbsp;&nbsp;&nbsp;<U>Employee Benefit Matters/Employees</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section</U><U></U><U>&nbsp;3.09(a)</U> of the Disclosure Letter sets forth a complete list of each material
(i)&nbsp;&#147;employee benefit plan&#148; as that term is defined in Section&nbsp;3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#147;<U>ERISA</U>&#148;) and (ii)&nbsp;employment, consulting, pension, retirement, profit
sharing, deferred compensation, stock option, change in control, retention, equity or equity-based compensation, stock purchase, employee stock ownership, severance pay, vacation, bonus or other compensation or incentive plans, programs, policies or
agreements, (iii)&nbsp;medical, vision, dental or other health plans, life insurance plans, or fringe benefit plans, in each case, whether oral or written, maintained or contributed to by the Company, or required to be maintained or contributed to
by the Company or otherwise providing for payments or benefits for or to any current or former employees, directors, officers or consultants of the Company and/or their dependents (collectively, the &#147;<U>Plans</U>&#148;). With respect to the
Plans listed on <U>Section</U><U></U><U>&nbsp;3.09(a)</U> of the Disclosure Letter, to the extent applicable, correct and complete copies of the following have been made available to Parent by the Company: (A)&nbsp;all Plans, including amendments
thereto; (B)&nbsp;the most recent annual report on Form 5500 filed with respect to each Plan (if required by applicable Law) and the most recent actuarial report in respect of any Plan that is a single employer pension plan subject to Title IV of
ERISA; (C)&nbsp;the most recent summary plan description or other equivalent written communications by the Company or its Affiliates for each Plan, if such written communications have previously been prepared and distributed to Company employees,
and all related summaries of material modifications; (D)&nbsp;the most recent Internal Revenue Service determination, notification or opinion letter, if any, received with respect to any applicable Plan; (E)&nbsp;each trust agreement relating to any
Plan (as applicable); (F) all material correspondence to or from the IRS, the Department of Labor or any other Governmental Entity during the past three years; and (G)&nbsp;any discrimination, coverage or similar annual tests performed during the
last two plan years. None of the Plans is subject to the Laws of a jurisdiction outside of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each Plan that is intended to be qualified under Section&nbsp;401(a) of the Code either has received a favorable
determination letter from the Internal Revenue Service or may rely upon a favorable prototype opinion letter from the Internal Revenue Service as to its qualified status, and, to the Knowledge of the Company, nothing has occurred since the date of
the latest </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
favorable determination letter or prototype opinion letter, as applicable, that would reasonably be expected to adversely affect the qualification of any such Plan. Each Plan and any related
trust complies and has been maintained and administered in material compliance with ERISA, the Code and other applicable Laws. Other than routine claims for benefits, there are no suits, claims, proceedings, actions, governmental audits or
investigations that are pending or, to the Knowledge of the Company, threatened against or involving any Plan or asserting any rights to or claims for benefits under any Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;No Plan is a &#147;multiemployer plan&#148; (as defined in Section&nbsp;3(37) or 4001(a)(3) of ERISA) (a
&#147;<U>Multiemployer Plan</U>&#148;) or other pension plan subject to Title&nbsp;IV of ERISA or Section&nbsp;412 of the Code, and neither the Company nor any ERISA Affiliate sponsors, maintains, or contributes to, or has, within the past six
(6)&nbsp;years, sponsored, maintained or contributed to, a Multiemployer Plan or other pension plan subject to Title&nbsp;IV of ERISA or Section&nbsp;412 of the Code. &#147;<U>ERISA Affiliate</U>&#148; shall mean any entity (whether or not
incorporated) other than the Company that, together with the Company, is required to be treated as a single employer under Section&nbsp;414(b), (c), (m) or (o)&nbsp;of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;No Plan provides for post-retirement or other post-employment welfare benefits (other than health care continuation
coverage as required by Section&nbsp;4980B of the Code or ERISA or coverage through the end of the calendar month in which a termination of employment occurs). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <U>Section</U><U></U><U>&nbsp;3.09(e)</U> of the Disclosure Letter, no Plan or other
Contract between the Company and an employee or other individual would reasonably be expected to result in any &#147;excess parachute payment&#148; within the meaning of Section&nbsp;280G(b)(1) of the Code, and no person is entitled to receive any
additional payment as a result of the imposition of any excise Tax under Section&nbsp;4999 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Except
as set forth on <U>Section</U><U></U><U>&nbsp;3.09(f)</U> of the Disclosure Letter, neither the execution by the Company of this Agreement nor the consummation of the transactions contemplated hereby will (either alone or upon occurrence of any
additional or subsequent events) (i)&nbsp;entitle any current or former employee, consultant or director of the Company or any group of such employees, consultants or directors to any payment of compensation; (ii)&nbsp;increase the amount of
compensation or benefits due to any such employee, consultant or director; or (iii)&nbsp;accelerate the vesting, funding or time of payment of any compensation, equity award or other benefit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Company is not the subject of any pending or, to the Knowledge of the Company, threatened proceeding relating
to any labor or employment matters involving any employee, including those relating to employment agreements, wages and hours, leave of absence, plant closing notification, employment statute or regulation, privacy right, labor dispute,
workers&#146; compensation policy or long-term disability policy, safety, retaliation, whistle blower, breach of public policy, immigration or discrimination matters, unfair labor practices or the equivalent or harassment complaints. The Company is
not a party to any collective bargaining agreement, and there are no labor unions or other organizations representing, or, to the Knowledge of the Company, purporting to represent or attempting to represent, any employee of the Company. There is no
pending or, to the Knowledge of the Company, threatened labor </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
strike, dispute, walkout, work stoppage, slowdown or lockout with respect to employees of the Company, and no such strike, dispute, walkout, slowdown or lockout has occurred within the past five
(5)&nbsp;years. Since January&nbsp;1, 2015, there has been no &#147;mass layoff,&#148; &#147;employment loss,&#148; or &#147;plant closing&#148; as defined by the Workers Adjustment and Retraining Notification Act, or any comparable federal, state
or local Law, whether domestic or international. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;The Company is in material compliance with all applicable
Laws, collective bargaining agreements and other material agreements or arrangements with any employee, works council, employee representative or other labor organization or group of employees, extension orders and binding customs respecting labor
and employment, including its own policies, practices, handbooks, work rules and internal regulations, relating to employment, including Laws relating to discrimination, hours of work and the payment of wages or overtime wages. Except as would not
reasonably be expected to result in a material liability to the Company, the Company (i)&nbsp;has withheld and reported and remitted all amounts required by Law or by agreement to be withheld and reported and remitted with respect to wages, salaries
and other payments to employees, (ii)&nbsp;is not liable for any: arrears of wages, compensation, severance pay or any Taxes or any penalty for failure to comply with any of the foregoing, and (iii)&nbsp;is not liable for any payment to any trust or
other fund governed by or maintained by or on behalf of any governmental authority, with respect to unemployment compensation benefits, social security or other benefits or obligations for employees (other than routine payments to be made in the
normal course of business and consistent with past practice). To the Knowledge of the Company, the Company is not the subject of investigation by any Governmental Entity relating to its employees or employment practices, and the Company is not a
party to a conciliation agreement, consent decree or other agreement or order with any Governmental Entity with respect to employment practices. The Company does not have current direct or indirect material liability with respect to any
misclassification of any person as an independent contractor or consultant rather than as an employee, or with respect to any employee leased from another employer or any employee currently or formerly classified as exempt from overtime wages or the
equivalent under applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;The employment of each employee of the Company is terminable by the Company
at will. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation</U>. Except for matters that have not resulted and would not reasonably
be expected to result, individually or in the aggregate, in a Material Adverse Effect, (a)&nbsp;there is no claim, action, suit, litigation, proceeding or governmental or administrative investigation, audit, inquiry or action (collectively,
&#147;<U>Legal Proceedings</U>&#148;) pending or, to the Knowledge of the Company, threatened against or relating to the Company, and (b)&nbsp;the Company is not subject to any outstanding order, writ, injunction or decree. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Title to Assets</U>. Except for matters that have not resulted and would not reasonably be
expected to result, individually or in the aggregate, in a Material Adverse Effect, the Company has good and valid title to all assets owned by it as of the date of this Agreement, including all assets (other than capitalized or operating leases)
reflected on the balance sheet of the Company as of September&nbsp;30, 2017 and included in the Company SEC Reports (except for assets sold or otherwise disposed of in the ordinary course of business since September&nbsp;30, 2017). Except for
matters that have not resulted and would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect, all of said assets are owned by the Company free and clear of any Liens (other than Permitted Liens). </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company has timely filed all income, franchise and other material Tax Returns required to be filed. All such Tax
Returns are complete and accurate in all material respects. The Company has paid all income, franchise and other material Taxes required to have been paid by it (whether or not shown on any Tax Return) other than Taxes that are not yet due and
payable or that are being contested in good faith in appropriate proceedings and that have been adequately reserved for to the extent required under GAAP. The Company is not currently the beneficiary of any extension of time within which to file any
Tax Return or pay any Tax. No claim has been made in writing by any Governmental Entity that the Company is or may be subject to taxation in a jurisdiction in which it does not file Tax Returns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;No deficiencies for Taxes of the Company have been claimed, proposed or assessed by any Governmental Entity. There
are no pending or, to the Knowledge of the Company, threatened audits, assessments or other actions for or relating to any material liability in respect to Taxes of the Company or any income, franchise or other material Tax Return of the Company. No
material closing agreement, private letter ruling, technical advice memoranda, advance pricing agreement, consent to an extension of time to make an election or consent to change a method of accounting, has been requested from, entered into with or
issued by any Governmental Entity with respect to the Company. The Company has made available to Parent or Parent&#146;s Representatives accurate and complete copies of all audit reports and similar documents (to which the Company has access)
relating to the Company&#146;s Tax Returns. The Company has not waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency. There are no Liens for Taxes upon any of the
assets of the Company except Liens for Taxes not yet due and payable (and for which there are adequate accruals, in accordance with GAAP). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The financial statements (including the related notes and schedules thereto) of the Company included (or
incorporated by reference) in the Company SEC Reports accrue all actual and contingent material liabilities for unpaid Taxes with respect to all periods through the dates thereof in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company has withheld and paid all material Taxes required to have been withheld and paid in connection with
amounts paid or owing to any employee, independent contractor, creditor, stockholder or other third party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The
Company has not constituted either a &#147;distributing corporation&#148; or a &#147;controlled corporation&#148; (within the meaning of Section&nbsp;355(a)(1)(A) of the Code) in a distribution intended to qualify for
<FONT STYLE="white-space:nowrap">Tax-free</FONT> treatment under Section&nbsp;355 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;The Company is
not a party to, or is not bound by, any Tax sharing, allocation or indemnification agreement or arrangement that will remain in effect after the Effective Time (other than customary <FONT STYLE="white-space:nowrap">gross-up</FONT> or indemnity
provisions in any credit agreement, employment agreement or similar commercial Contract, the primary purpose of which does not relate to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Taxes). The Company is not, and has not been, a member any &#147;affiliated group&#148; as defined in Section&nbsp;1504 of the Code filing a consolidated United States federal income Tax Return
or other group filing a consolidated, combined, affiliated, unitary or similar income Tax Return. The Company has no liability for Taxes of any Person under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any
similar provision of local, state or foreign Law), or as a transferee or successor, by Contract or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Company will not be required to include any material item of income or gain in, or exclude any material item of
deduction or loss from, taxable income for any taxable period (or portion thereof) ending after the Effective Time as a result of any (i)&nbsp;change in method of accounting, or use of an improper method of accounting, for a taxable period ending on
or prior to the Effective Time, (ii)&nbsp;&#147;closing agreement&#148; as described in Section&nbsp;7121 of the Code (or any corresponding or similar provision of state or local income Tax Law) executed on or prior to the Effective Time,
(iii)&nbsp;installment sale or open transaction entered into on or prior to the Effective Time, or (iv)&nbsp;prepaid amount received on or prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not been a party to a transaction that, as of the date of this Agreement, constitutes a
&#147;listed transaction&#148; as defined in Treasury Regulations <FONT STYLE="white-space:nowrap">1.6011-4(b)(2)</FONT> (or a similar provision of state Law). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;The Company does not have, and never has had, any direct or indirect interest in any trust, partnership,
corporation, limited liability company, or other &#147;business entity&#148; for U.S.&nbsp;federal income Tax purposes. To the Knowledge of the Company, the Company is not subject to any Tax payment obligation or Tax Return filing obligation in any
jurisdiction outside the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Either (i)&nbsp;the Company is not, and has not been, a United States
real property holding corporation within the meaning of Section&nbsp;897(c)(2) of the Code during the applicable period specified in Section&nbsp;897(c)(1)(A)(ii), or (ii)&nbsp;the Company Shares are regularly traded on an established securities
market within the meaning of Section&nbsp;1445(b)(6) of the Code and Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.897-9T(d)(2).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, (i)&nbsp;&#147;<U>Tax</U>&#148; shall mean any federal, state, provincial, local or
foreign taxes, levies, duties, tariffs, customs, imposts and other similar charges of whatever kind or nature imposed by a Governmental Entity, including any income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation,
premium, windfall or other profits, environmental, customs duties, capital stock, capital gains, franchise, profits, withholding, social security (or similar), unemployment, disability, real property, personal property, sales, use, transfer,
registration, ad&nbsp;valorem, value added, alternative or <FONT STYLE="white-space:nowrap">add-on</FONT> minimum or estimated tax, or other tax of any kind whatsoever, including any interest, penalty or addition thereto, whether disputed or not;
and (ii)&nbsp;&#147;<U>Tax Return</U>&#148; shall mean any report (including any information report), declaration, return, information return, schedule, claim for refund, or statement relating to Taxes, including any schedule or attachment thereto,
and including any amendments thereof, filed or required to be filed with a Governmental Entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with Law</U>. Except for matters that
have not resulted and would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect, (a)&nbsp;the Company is not, nor has it been since January&nbsp;1, 2015, in conflict with, in default with respect to
or in violation of, any statute, law, ordinance, rule, regulation, order, judgment, decree or requirement of a Governmental Entity (&#147;<U>Laws</U>&#148;) applicable to the Company or by which any property or asset of the Company is bound or
affected, (b)&nbsp;the Company has all permits, licenses, authorizations, consents, approvals and franchises from Governmental Entities required to conduct its business as currently conducted (&#147;<U>Permits</U>&#148;) and such Permits are valid
and in full force and effect and (c)&nbsp;the Company has not received written notice, or to the Knowledge of the Company, any other communication, from any Governmental Entity threatening to revoke any such Permit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Environmental Matters</U>. Except for matters that have not resulted and would not reasonably be
expected to result, individually or in the aggregate, in a Material Adverse Effect: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company is, and has
been at all times since January&nbsp;1, 2015, in compliance with all applicable Environmental Laws. There is no investigation, suit, claim, action or proceeding relating to or arising under Environmental Laws that is pending or, to the Knowledge of
the Company, threatened against or affecting the Company or any real property currently or, to the Knowledge of the Company, formerly owned, operated or leased by the Company. The Company has not received any written notice of or entered into or
assumed (by Contract or operation of Law or otherwise), any obligation, liability, order, settlement, judgment, injunction or decree relating to or arising under Environmental Laws. No facts, circumstances or conditions exist that would reasonably
be expected to result in the Company incurring environmental liabilities. Neither the execution and delivery of this Agreement by the Company, nor the consummation by the Company of the transactions contemplated hereby, nor compliance by the Company
with any of the provisions hereof, will trigger a requirement for an environmental investigation of any property or result in the termination or revocation of, or a right of termination or cancellation under, any Environmental Permit. There have
been no Releases of Hazardous Substances on properties currently (or, to the Knowledge of the Company, formerly) owned, operated or leased by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company has obtained and currently maintains all Permits necessary under Environmental Laws for its operations
(&#147;<U>Environmental Permits</U>&#148;), there is no investigation known to the Company, nor any action pending or, to the Knowledge of the Company, threatened against or affecting the Company or any real property operated or leased by the
Company to revoke such Environmental Permits, and the Company has not received any written notice from any Person to the effect that there is lacking any Environmental Permit required under Environmental Law for the current use or operation of any
property operated or leased by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of the Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Environmental Laws</U>&#148; means all Laws relating (A)&nbsp;the protection, preservation
or restoration of the environment (including air, surface water, groundwater, drinking water supply, surface and subsurface soils and strata, wetlands, plant and animal life or any other natural resource), (B)&nbsp;the exposure to, or the use,
storage, recycling, treatment, generation, transportation, processing, handling, labeling, production, Release or disposal of Hazardous Substances or (C)&nbsp;the protection of employees from work-related hazards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Hazardous Substances</U>&#148; means any
substance listed, defined, designated, classified or regulated as a waste, pollutant or contaminant or as hazardous, toxic, radioactive or dangerous or any other term of similar import under any Environmental Law, including petroleum. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Release</U>&#148; means any release, spill, emission, discharge, migration, leaking,
pouring, dumping or emptying, pumping, injection, deposit, disposal or leaching into the environment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15.&nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual Property</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section</U><U></U><U>&nbsp;3.15(a)</U> of the Disclosure Letter sets forth a true and complete list of all
Intellectual Property owned or exclusively licensed to the Company (or <FONT STYLE="white-space:nowrap">non-exclusively</FONT> licensed to the Company and material to the conduct of the Company&#146;s business as currently conducted) and which, in
each case, is registered or subject to an application for issuance of a patent or registration in any jurisdiction throughout the world (the &#147;<U>Company Registered Intellectual Property</U>&#148;), together with the name of the current owner(s)
(including joint owners), the applicable jurisdictions, the application or registration numbers and the date of application and issuance or registration. Except as otherwise indicated in <U>Section</U><U></U><U>&nbsp;3.15(a)</U> of the Disclosure
Letter, the Company is the exclusive owner of all Company Registered Intellectual Property. Without limiting the foregoing, to the Knowledge of the Company, each Person who is or was an employee or contractor (individually or as a contracting
entity) of the Company and who is or was involved in the creation or development of any Company Registered Intellectual Property for or on behalf of the Company has executed a valid, enforceable agreement containing an assignment to the Company of
all of such employee&#146;s rights (and (x)&nbsp;in the case of an individual contractor, of all such contractor&#146;s rights, and (y)&nbsp;in the case of a contracting entity, all of such contracting entity&#146;s rights) to such Company
Registered Intellectual Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company is the sole and exclusive or joint owner of or has a valid and
legally enforceable license to use, in each case, free and clear of any Liens other than Permitted Liens, all Company Registered Intellectual Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, and except as set forth in Section&nbsp;3.18(a) of the Disclosure Letter as
expired, lapsed or abandoned, all Company Registered Intellectual Property is subsisting and, with respect to issued patents and registered trademarks within the Company Registered Intellectual Property, is valid and enforceable. To the knowledge of
the Company, all maintenance and renewal fees having <FONT STYLE="white-space:nowrap">non-extendible</FONT> due dates for payment prior to the date of this Agreement and that are necessary to preserve the material rights of the Company in connection
with the Company Registered Intellectual Property listed in <U>Section</U><U></U><U>&nbsp;3.15(a)</U> of the Disclosure Letter have been paid. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of Company, no third party which is not the U.S. Patent and Trademark Office or any foreign
governmental administrative agency for patent and/or trademark matters (the &#147;<U>Governmental Patent Authority</U>&#148;) is overtly challenging in writing the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
right, title or interest of any of the Company or any licensor of the Company in, to or under the Company Registered Intellectual Property, or the validity, enforceability or claim construction
of any patents within the Company Registered Intellectual Property. To the Knowledge of the Company, there is no post-grant proceeding, interference, reissue, reexamination, post-grant review, inter partes reexamination, supplemental examination,
opposition, revocation, cancellation, proceeding, or objection, in each case initiated by a third party other than a Governmental Patent Authority, pending with regard to any Company Registered Intellectual Property. To the Knowledge of the Company,
none of the Company Registered Intellectual Property is subject to any outstanding order of, judgment of, decree of or agreement with any Governmental Entity other than a Governmental Patent Authority that limits the ability of the Company to
exploit any Company Registered Intellectual Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Except for matters that have not resulted and would not
reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect, and to the Knowledge of the Company, the operation of the business of the Company as currently conducted does not infringe, violate or misappropriate
the Intellectual Property of any third party. Since January&nbsp;1, 2015, the Company has not received any written notice from any third party alleging that the operation of the business of the Company as currently conducted infringes, violates or
misappropriates the Intellectual Property of such third party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Except as has resulted or would reasonably be
expected to result, individually or in the aggregate, in a Material Adverse Effect, to the Knowledge of the Company, no third party, including any employee or former employee of the Company, is infringing, violating or misappropriating any of the
Intellectual Property of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Except for matters that have not resulted and would not reasonably be
expected to result, individually or in the aggregate, in a Material Adverse Effect, to the Knowledge of the Company, no funding, facilities or personnel of any Governmental Entity or any university, college, research institute or other educational
institution have been or are being used, directly or indirectly, to develop or create, in whole or in part, any Company IP, except for any such funding or use of facilities or personnel that does not result in such Governmental Entity or institution
obtaining ownership or use rights to such Company IP, or require or obligate the Company to grant or offer to any Governmental Entity or institution any license or right to such Company IP or require the Company to reimburse or repay any grant under
any contingent or <FONT STYLE="white-space:nowrap">non-contingent</FONT> payment obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;The Company has
taken reasonable commercial efforts to maintain the confidentiality of and otherwise protect and enforce its rights in all proprietary information held by the Company, or purported to be held by the Company in its public filings or by officers of
the Company, as a trade secret, the value of which is contingent upon maintaining the confidentiality thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, (i)&nbsp;no individual involved in the creation, discovery, or development of any
Company IP owned by the Company, or purported to be owned by the Company in its public filings or by officers of the Company, is entitled to make any claim for the benefit of that individual to: (A)&nbsp;any right, title or interest in such Company
IP; or (B)&nbsp;any compensation or remuneration in relation to the exploitation of such Company IP, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(ii) in the case of patents within the Company IP, no compensation is owed to any individual who at any time was employed or otherwise engaged by the Company in connection with the conception or
reduction to practice of material inventions disclosed in such patents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, the
Company has the right to use all data generated in the course of, or as a result of, any clinical trial or other testing in humans or any manufacture of products or product candidates in each case, conducted by or on behalf of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, neither the execution, delivery or performance of this Agreement by the Company
nor the consummation of any transactions hereunder will result in any material limitation on the Company&#146;s right, title or interest in or to any of the Company IP or result in a breach of, default under or termination of any Contract with
respect to Company IP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company IP</U>&#148; shall mean (a)&nbsp;all Intellectual Property that is owned by the
Company or purported to be owned by the Company in its public filings or by officers of the Company, and (b)&nbsp;all Intellectual Property licensed to the Company, other than pursuant to software license agreements entered in the ordinary course of
business consistent with past practice for any third-party <FONT STYLE="white-space:nowrap">non-customized</FONT> commercially available software. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Intellectual Property</U>&#148; shall mean, in any jurisdiction throughout the world,
(i)&nbsp;patents and applications therefor, including all certificates of invention, provisionals, nonprovisionals, substitutions, divisionals, continuations,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> reissues, extensions, supplementary protection certificates, reexaminations, term extensions and the equivalents of any of the foregoing in any
jurisdiction, (ii)&nbsp;trade secrets and <FONT STYLE="white-space:nowrap">know-how,</FONT> (iii)&nbsp;copyright registrations and applications therefor, works of authorship, and moral rights, (iv)&nbsp;computer software, including all source code,
object code and related documentation, (v)&nbsp;trademarks, service marks, brand names, logos, certification marks, trade names, corporate names and other indications of origin, registrations and applications to register the foregoing, including any
extension, modification or renewal of any such registration or application, and all goodwill associated with any of the foregoing, (vi)&nbsp;registered domain names and social media properties, and (vii)&nbsp;all U.S. and foreign rights arising
under or associated with any of the foregoing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16.&nbsp;&nbsp;&nbsp;&nbsp;<U>Real Property</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company does not own any real property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section</U><U></U><U>&nbsp;3.16(b)</U> of the Disclosure Letter sets forth a true, correct and complete list of
all leases, subleases and other agreements under which the Company uses or occupies or has the right to use or occupy, now or in the future, any real property (the &#147;<U>Real Property Leases</U>&#148;). The Company has heretofore made available
to Parent true, correct and complete copies of all Real Property Leases (including all modifications, amendments, supplements, waivers and side </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
letters thereto). Except for matters that would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect, (i)&nbsp;each Real Property Lease is valid,
binding and in full force and effect, all rent and other sums and charges payable by the Company as tenant thereunder are current, (ii)&nbsp;no termination event or condition or uncured default on the part of the Company or, to the Knowledge of the
Company, the landlord thereunder exists under any Real Property Lease, (iii)&nbsp;the Company has a good and valid leasehold interest in each parcel of real property leased by it free and clear of all Liens, except for (A)&nbsp;those reflected or
reserved against in the balance sheet of the Company as of September&nbsp;30, 2017, and included in the Company SEC Reports, (B)&nbsp;Taxes and general and special assessments not in default and payable without penalty and interest and (C)&nbsp;any
Permitted Liens and (iv)&nbsp;the Company has not received written notice of any pending, and, to the Knowledge of the Company, there is no threatened, condemnation with respect to any property leased pursuant to any of the Real Property Leases.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17.&nbsp;&nbsp;&nbsp;&nbsp;<U>Material Contracts</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Section</U><U></U><U>&nbsp;3.17(a)</U> of the Disclosure Letter lists as of the date hereof, and the Company has
made available to Parent and Purchaser (or outside counsel) true, correct and complete (subject to any necessary redactions) copies of, all Contracts to which the Company is a party or by which the Company or any of its properties or assets is bound
that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;would be required to be filed by the Company as a &#147;material contract&#148; pursuant
to Item&nbsp;601(b)(10) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;contains covenants that materially limit (now or in the future, including pursuant to any
subsequent act or omission) the ability of the Company: (A)&nbsp;to compete in any business or with any Person or in any geographic area or to sell, supply or distribute any service or product (including any
<FONT STYLE="white-space:nowrap">non-compete,</FONT> exclusivity or &#147;most-favored nation&#148; provisions), (B)&nbsp;to purchase or acquire an interest in any other entity, except, in each case, for any such Contract that may be cancelled
without notice or penalty or other liability of the Company upon notice of ninety (90)&nbsp;days or less, (C)&nbsp;to enforce its rights under any Contract, agreement or applicable Law, including any covenant not to sue, or (D)&nbsp;make use of any
Company IP; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;provides for or governs the formation, creation, operation, management or control
of any partnership or joint venture; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;relating to the lease or sublease of Real Property
Leases; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;involves (A)&nbsp;a third party granting the Company a license, right or immunity
(including any covenant not to sue) to any material Intellectual Property (other than shrink-wrap, click-wrap and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> or commercially available software) or
(B)&nbsp;the joint development of Intellectual Property, products or technology with a third party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;contains continuing obligations or interests involving (A)&nbsp;milestone or similar payments or
(B)&nbsp;payments or royalties or other amounts calculated based upon any revenues or income of the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;except for Contracts disclosed under
<U>Section</U><U></U><U>&nbsp;3.09(a)</U> above, requires or permits the Company, or any successor to or acquiror of the Company, to make any payment to another Person as a result of a merger or change of control of the Company or gives another
Person a right to receive or elect to receive such a payment (in each case, other than with respect to any Contract providing for any such payment made to a Company employee); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;involves sole-source or single-source suppliers of material tangible products or services
(including any of the Company&#146;s products or product candidates); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp;involves the license by
the Company of any of the material Company Registered Intellectual Property to any third party (other than as ancillary to a sale of products to customers); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;constitutes a material manufacturing, supply, distribution or marketing agreement that
(A)&nbsp;provides for minimum payment obligations by the Company in excess of $750,000 (x)&nbsp;since January&nbsp;1, 2017 or (y)&nbsp;during any prospective twelve (12)&nbsp;month period or (B)&nbsp;contains a covenant not to sue a third party;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi)&nbsp;&nbsp;&nbsp;&nbsp;relates to indebtedness or any financial guaranty thereof, in each case, having an outstanding
principal amount in excess of $750,000; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii)&nbsp;&nbsp;&nbsp;&nbsp;was entered into after January&nbsp;1, 2015, or has
not yet been consummated, and involves the acquisition or disposition, directly or indirectly (by merger or otherwise), of a business or capital stock or other equity interest of another Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;by its terms calls for aggregate payments or receipts by the Company in excess of $750,000
(A)&nbsp;since January&nbsp;1, 2017 or (B)&nbsp;over its remaining term (including by means of royalty payments); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;that individually or together with any other Contracts with a Person (or group of affiliated
Persons), the breach or termination of which would reasonably be expected to have or result in a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Contract of the type
described in clauses&nbsp;(i) through (xiv)&nbsp;above, other than a Plan, is referred to herein as a &#147;<U>Material Contract</U>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as has not resulted and would not reasonably be expected to result, individually or in the aggregate, in a
Material Adverse Effect, (i)&nbsp;each Material Contract is valid and binding on the Company and, to the Knowledge of the Company, each other party thereto, and is in full force and effect, (ii)&nbsp;the Company has performed and complied with all
obligations required to be performed or complied with by it under each Material Contract and, to the Knowledge of the Company, each other party to each Material Contract has performed all obligations required to be performed by it under such
Material Contract, and (iii)&nbsp;there is no default under any Material Contract by the Company or, to the Knowledge of the Company, by any other party, and no event has occurred that with the lapse of time or the giving of notice or both would
constitute a default thereunder by the Company or, to the Knowledge of the Company, by any other party thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as expressly set forth in the terms of the Amended and Restated
License, Development and Commercialization Agreement by and between the Company and Eli Lilly&nbsp;&amp; Co. (&#147;<U>Eli Lilly</U>&#148;) dated March&nbsp;22, 2017 (the &#147;<U>Eli Lilly Agreement</U>&#148;), Company has no material ongoing
liability or material potential liability to Eli Lilly or its Affiliates arising out of the Original Agreement (as defined in the Eli Lilly Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18.&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory Compliance</U>. Except as has not resulted and would not reasonably be expected to
result, individually or in the aggregate, in a Material Adverse Effect: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company is, and since
January&nbsp;1, 2015 has been, in compliance with all Laws administered by the United States Food and Drug Administration (the &#147;<U>FDA</U>&#148;) applicable to the Company, or by which any property, business product or other asset of the
Company is bound or affected, including the Federal Food, Drug and Cosmetic Act (21&nbsp;U.S.C. &#167;&#167;&nbsp;301 et&nbsp;seq.) and the regulations promulgated thereunder (collectively, &#147;<U>FDA Laws</U>&#148;). To the Knowledge of the
Company, the Company has not received any written notification of any pending or threatened claim, suit, proceeding, hearing, enforcement, audit, investigation or arbitration from any Governmental Entity, including the FDA, alleging potential or
actual <FONT STYLE="white-space:nowrap">non-compliance</FONT> by, or liability of, the Company under any FDA Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company is, and since January&nbsp;1, 2015 has been, in compliance with all healthcare Laws applicable to the
operation of its business as currently conducted, including any and all federal, state and local fraud and abuse Laws, or any regulations promulgated thereunder, including, without limitation, (i)&nbsp;the federal Anti- Kickback Statute
(42&nbsp;U.S.C. &#167;&nbsp;1320a- 7(b)), (ii)&nbsp;the civil False Claims Act (31&nbsp;U.S.C. &#167;&nbsp;3729 et&nbsp;seq.), (iii)&nbsp;the federal Physician Self-Referral (Stark) Law (42&nbsp;U.S.C. &#167;&nbsp;1395nn), and (iv)&nbsp;the Civil
Monetary Penalties Law (42&nbsp;U.S.C. &#167;&#167;1320a&#150;7a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company holds such Permits of the FDA
required for the conduct of its business as currently conducted (collectively, the &#147;<U>FDA Permits</U>&#148;) and all such FDA Permits are in full force and effect. The Company has fulfilled and performed all of its obligations with respect to
the FDA Permits, and no event has occurred which allows, or after notice or lapse of time would allow, revocation or termination thereof or results in any other material impairment of the rights of the holder of any FDA Permit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, the clinical and <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies
conducted by or on behalf of or sponsored by the Company were and, if still pending, are being conducted in accordance with standard medical and scientific research procedures and all applicable FDA Laws. The Company has not received any written
notices or correspondence, to the Knowledge of the Company, any oral correspondence from the FDA or any other Governmental Entity performing functions similar to those performed by the FDA with respect to any ongoing clinical or <FONT
STYLE="white-space:nowrap">pre-</FONT> clinical studies requiring the termination, suspension or material modification of such studies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;To the Knowledge of the Company, and except as has not resulted and would not reasonably be expected to result,
individually or in the aggregate, in a Company Material Adverse Effect, the Company is, and each Person acting on its behalf (including any Third Party Service Provider) is, and has been, in material compliance with (i)&nbsp;all applicable Laws
relating to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the privacy, data protection and security of any Personal Information, (ii)&nbsp;all privacy, data protection and security policies of the Company concerning patient medical records and other
Personal Information, and (iii)&nbsp;any contractual requirements to which the Company is subject that relate to any of the foregoing. To the Knowledge of the Company, and except as has not resulted and would not reasonably be expected to result,
individually or in the aggregate, in a Company Material Adverse Effect, neither the Company nor any Third Party Service Provider, has experienced or been notified in writing of any security breaches with respect to (including any that have resulted
in the public disclosure of or any other unauthorized access to) any Personal Information or any confidential information of the Company. The Company has, and, to the Knowledge of the Company, each of its Third Party Service Providers has, taken
reasonable actions and implemented policies and procedures which, in each case, are reasonably appropriate to protect and maintain the security of all Personal Information and confidential information of the Company, including from any unauthorized
access or use. The Company has not received, since January&nbsp;1, 2015, a written (or to the Knowledge of the Company, oral) complaint regarding the Company&#146;s use, collection, storage, disclosure, receipt or transfer of Personal Information.
To the Knowledge of the Company, and except as has not resulted and would not reasonably be expected to result, individually or in the aggregate, in a Company Material Adverse Effect, the execution, delivery and performance of this Agreement will
comply with all applicable Laws relating to privacy and with the Company&#146;s privacy policies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Neither the
Company or, to the Knowledge of the Company, any of its employees is or has been (i)&nbsp;debarred from participation in any program related to pharmaceutical products pursuant to 21&nbsp;U.S.C. Section&nbsp;335a (a)&nbsp;or (b)&nbsp;or, to the
Knowledge of the Company, any corresponding state or foreign Law, or (ii)&nbsp;listed on the Office of Inspector General for the Department of Health and Human Services or the General Services Administration excluded persons list, and there are no
proceedings pending or, to the Knowledge of the Company, threatened that would be reasonably likely to result in criminal liability or debarment or disqualification by any Governmental Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not, to its Knowledge: (i)&nbsp;made an untrue statement of a material fact or fraudulent statement
to the FDA or any Governmental Entity, (ii)&nbsp;failed to disclose a material fact required to be disclosed to the FDA, (iii)&nbsp;committed any other act, made any statement or failed to make any statement, that (in any such case) establishes a
reasonable basis for the FDA to invoke its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Final Policy. The Company is not the subject of any pending or, to the Knowledge of the Company, threatened investigation by the
FDA pursuant to its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Final Policy </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;The Company&#146;s diagnostic tests developed by the Company for use with each of the product candidates, drugs or
compounds that the Company is developing or seeking regulatory approval for as of the date of this Agreement (including taladegib, entrectinib and <FONT STYLE="white-space:nowrap">RXDX-105,</FONT> <FONT STYLE="white-space:nowrap">RXDX-106,</FONT> <FONT
STYLE="white-space:nowrap">RXDX-107,</FONT> and <FONT STYLE="white-space:nowrap">RXDX-109)</FONT> were designed to be lawfully marketed under the Federal Food, Drug, and Cosmetic Act (21&nbsp;U.S.C. &#167;&nbsp;201 et&nbsp;seq.) as presently
enforced by the FDA pursuant to its exercise of enforcement discretion over laboratory developed tests (&#147;<U>LDTs</U>&#148;). With respect to any diagnostic assays not lawfully marketed as LDTs, the Company has complied with all FDA regulations
regarding use of investigational medical devices, such as the Investigational Device Exemption regulations under 21 C.F.R. Part&nbsp;812, and have obtained clearance or approval from the FDA as required, except in each case where any <FONT
STYLE="white-space:nowrap">non-compliance</FONT> has not had and would not reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19.&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>.
<U>Section</U><U></U><U>&nbsp;3.19</U> of the Disclosure Letter sets forth a true, correct and complete list of all currently effective material insurance policies issued in favor of the Company, or pursuant to which the Company is a named insured
or otherwise a beneficiary. Except for matters that have not resulted and would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect, the Company is covered by valid and currently effective insurance
policies issued in favor of the Company that the Company believes to be customary and adequate for companies of similar size in the industries and locations in which the Company operates. Except for matters that have not resulted and would not
reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect, with respect to each such insurance policy, (a)&nbsp;the policy is in full force and effect and all premiums due thereon have been paid, (b)&nbsp;the
Company is not in breach or default, and the Company has not taken any action or failed to take any action which, with notice or the lapse of time or both, would constitute such a breach or default, or permit termination or modification of, any such
policy, and (c)&nbsp;to the Knowledge of the Company, no insurer on any such policy has been declared insolvent or placed in receivership, conservatorship or liquidation, and no notice of cancellation or termination has been received with respect to
any such policy. The Company maintains mandatory insurance policies in compliance in all material respects with applicable Law. Except for matters that have not resulted and would not reasonably be expected to result, individually or in the
aggregate, in a Material Adverse Effect, there is no claim pending under any of the Company&#146;s insurance policies as to which coverage has been questioned, denied or disputed by the underwriters of such policies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.20.&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain Payments</U>. Except for matters that have not resulted and would not reasonably be
expected to result, individually or in the aggregate, in a Material Adverse Effect, the Company has not (nor, to the Knowledge of the Company, have any of its Representatives) (a)&nbsp;used any corporate funds for any illegal contributions, gifts,
entertainment or other unlawful expenses relating to political activity, (b)&nbsp;used any corporate funds for any direct or indirect unlawful payments to any foreign or domestic government officials or employees, (c)&nbsp;violated any provision of
the Foreign Corrupt Practices Act of 1977 or similar applicable foreign, federal or state Law, (d)&nbsp;established or maintained any unlawful fund of corporate monies or other properties or (e)&nbsp;made any bribe, unlawful rebate, unlawful payoff,
influence payment, kickback or other unlawful payment of any nature. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21.&nbsp;&nbsp;&nbsp;&nbsp;<U>Related Party
Transactions</U>. No current director, officer, Affiliate or Associate of the Company (a)&nbsp;has outstanding any indebtedness to the Company or is owed any indebtedness from the Company (other than liabilities occurred in the ordinary course of
business and consistent with past practices) or (b)&nbsp;is otherwise a party to, or directly or indirectly benefits from, any material Contract with the Company of a type that would be required to be disclosed under Item&nbsp;404 of Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT> under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22.&nbsp;&nbsp;&nbsp;&nbsp;<U>Opinion of Financial
Advisors of the Company</U>. Prior to the execution of this Agreement, the Company has received an opinion from each of the Company Financial Advisors, to the effect that, as of the date thereof and based upon and subject to the matters set forth
therein, the Offer Price is fair to the stockholders of the Company from a financial point of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
view, and each such opinion has not been withdrawn or modified. As soon as practicable following the date hereof, an executed copy of each such opinion will be made available to Parent for
informational purposes only. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23.&nbsp;&nbsp;&nbsp;&nbsp;<U>Takeover Statutes</U>. The Company Board has taken all actions
so that the restrictions applicable to business combinations contained in Section&nbsp;203 of the DGCL are inapplicable to the execution, delivery and performance of this Agreement and to the consummation of the Offer, the Merger and the other
Transactions. To the Knowledge of the Company, no &#147;moratorium,&#148; &#147;fair price,&#148; &#147;business combination,&#148; &#147;control share acquisition&#148; or similar provision of any state anti-takeover Law (collectively,
&#147;<U>Takeover Laws</U>&#148;) is applicable to this Agreement or the tender and support agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.24.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Vote Required</U>. No vote of the holders of any class or series of Company Shares is
necessary to approve this Agreement or to consummate the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.25.&nbsp;&nbsp;&nbsp;&nbsp;<U>Information
Supplied</U>. Each document required to be filed by the Company with the SEC in connection with the Offer, the Merger and the other Transactions (collectively, the &#147;<U>Company Disclosure Documents</U>&#148;) (including the Schedule <FONT
STYLE="white-space:nowrap">14D-9),</FONT> and any amendments or supplements thereto, when filed, distributed or disseminated, as applicable, will comply as to form in all material respects with the applicable requirements of the Exchange Act. None
of the Company Disclosure Documents will, on the date of such filing or mailing to the Company Stockholders, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to
make the statements therein, in light of the circumstances under which they are made, not misleading. None of the information with respect to the Company that the Company furnishes to Parent or Purchaser in writing specifically for inclusion or
incorporation by reference in the Offer Documents will, at the time the Offer Documents are filed with the SEC, at any time the Offer Documents are amended or supplemented, or at the time the Offer Documents are first distributed or otherwise
disseminated to the Company Stockholders, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading. Notwithstanding the foregoing, no representation or warranty is made by the Company with respect to statements made or incorporated by reference in the Offer Documents or the Schedule <FONT
STYLE="white-space:nowrap">14D-9</FONT> based on information supplied by or on behalf of Parent in writing specifically for inclusion or incorporation by reference therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.26.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Other Representations or Warranties</U>. Without limiting Parent&#146;s rights in the case of
common law fraud or any Willful and Material Breach of this Agreement, except for the representations and warranties contained in this <U>Article</U><U></U><U>&nbsp;III</U> or in the certificate to be delivered by the Company in connection with the
Offer and the Merger, neither the Company nor any other Person on behalf of the Company makes any express or implied representation or warranty with respect to the Company or with respect to any other information provided to Parent or Purchaser in
connection with the transactions contemplated hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES OF PARENT AND PURCHASER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Parent and Purchaser represent and warrant to the Company as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization and Qualification</U>. Each of Parent and Purchaser is a duly organized and validly
existing corporation in good standing under the Laws of the jurisdiction of its organization. All of the issued and outstanding capital stock of Purchaser is owned directly or indirectly by Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02.&nbsp;&nbsp;&nbsp;&nbsp;<U>Authority</U>. Each of Parent and Purchaser has requisite corporate power and authority to
execute and deliver this Agreement and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement by Parent and Purchaser and, subject to the adoption of this Agreement by Parent, as the sole stockholder of
Purchaser (which adoption shall occur immediately after the execution and delivery of this Agreement), the consummation of the transactions contemplated hereby have been duly and validly authorized by all necessary corporate proceedings on the part
of Parent and Purchaser (including by their respective boards of directors). This Agreement has been duly and validly executed and delivered by Parent and Purchaser and constitutes a valid and binding obligation of each of Parent and Purchaser,
enforceable against each of Parent and Purchaser in accordance with its terms, except to the extent that enforceability may be limited by applicable bankruptcy Laws, insolvency, moratorium, reorganization or other similar Laws affecting the
enforcement of creditors&#146; rights generally or by general principles of equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03.&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Conflicts; Consents and Approvals</U>. Except as would not materially and adversely affect Parent&#146;s or Purchaser&#146;s ability to consummate the transactions contemplated hereby, neither the execution and delivery of this Agreement by Parent
or Purchaser nor the consummation of the transactions contemplated hereby will (a)&nbsp;violate or conflict with or result in any breach of any provision of the respective certificate of incorporation or bylaws (or other similar governing documents)
of Parent or Purchaser, (b)&nbsp;require any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Entity, except (i)&nbsp;as may be required under the HSR Act and any Foreign Antitrust Laws,
(ii)&nbsp;the applicable requirements of the Exchange Act and the rules and regulations promulgated thereunder, or (iii)&nbsp;the filing and recordation of appropriate merger documents as required by the DGCL, (c)&nbsp;violate, conflict with or
result in a breach of any provision of, or require any consent, waiver or approval or result in a default (or give rise to any right of termination, cancellation, modification or acceleration or any event that, with the giving of notice, the passage
of time or otherwise, would constitute a default or give rise to any such right) under any of the terms, conditions or provisions of any material Contract to which Parent or Purchaser or any of their respective Subsidiaries is a party or by which
the assets of Parent or any of their respective Subsidiaries may be bound or (d)&nbsp;violate any order, writ, injunction, decree, statute, rule or regulation applicable to Parent or Purchaser or any of their respective Subsidiaries or by which any
of their respective assets are bound. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.04.&nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation</U>. Except as would not materially and
adversely affect Parent&#146;s or Purchaser&#146;s ability to consummate the transactions contemplated hereby, (a)&nbsp;as of the date hereof, there is no Legal Proceeding pending or, to the knowledge of Parent, threatened against
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or relating to Parent or any of its Subsidiaries, and (b)&nbsp;neither Parent nor any of its Subsidiaries is subject to any outstanding order, writ, injunction or decree that imposes any legal
restraint on or prohibition against the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.05.&nbsp;&nbsp;&nbsp;&nbsp;<U>Interested Stockholder</U>. Neither Parent nor any of its Subsidiaries is, or since has been at
any time during the period commencing three (3)&nbsp;years prior to the date hereof through the date hereof, an &#147;interested stockholder&#148; of the Company, as such term is defined in Section&nbsp;203 of the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.06.&nbsp;&nbsp;&nbsp;&nbsp;<U>Sufficient Funds</U>. Parent has, and will continue to have from the date hereof until the
Effective Time, the funds necessary to consummate the Offer and the Merger and pay the Offer Price or the Merger Consideration, as applicable, to holders of Shares, the Option Consideration to the holders of the Company Options, RSU Consideration to
the holders of the Restricted Stock Units and the Warrant Consideration to the holders of the Company Warrants, and to pay all other costs, fees and expenses incurred by Parent, Purchaser and the Company in connection with this Agreement and the
transactions contemplated by this Agreement. Parent expressly agrees and acknowledges that its obligations hereunder, including its and Purchaser&#146;s obligations to consummate the Offer and the Merger, are not subject to, or conditioned on,
Parent&#146;s or Purchaser&#146;s receipt of financing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.07.&nbsp;&nbsp;&nbsp;&nbsp;<U>Brokers</U>. The Company will not be
responsible for any brokerage, finder&#146;s, financial advisor&#146;s or other fee or commission payable to any broker, finder or investment banker in connection with the transactions contemplated by this Agreement based upon arrangements made by
and on behalf of Parent and Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.08.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Other Information</U>. Parent and Purchaser
acknowledge that the Company makes no representations or warranties as to any matter whatsoever regarding the subject matter of this Agreement except as expressly set forth in <U>Article</U><U></U><U>&nbsp;III</U>, including the Company Disclosure
Letter and in the certificate to be delivered by the Company in connection with the Offer. Notwithstanding anything to the contrary contained in this <U>Section</U><U></U><U>&nbsp;4.08</U> or elsewhere in this Agreement, nothing in this
<U>Section</U><U></U><U>&nbsp;4.08</U> will operate to limit any right or remedy that Parent, Purchaser or any of their respective Representatives may have against any Person for common law fraud or any Willful and Material Breach of this Agreement
by the Company or any of the Company&#146;s Affiliates or Representatives. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;V </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conduct of Business of the Company</U>. During the period from the date of this Agreement and
continuing until the earlier of the Effective Time or the termination of this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;7.01</U>, except as (x)&nbsp;consented to in writing by Parent (which consent shall not be unreasonably
withheld, conditioned or delayed), (y)&nbsp;specifically required by this Agreement or (z)&nbsp;set forth in <U>Section</U><U></U><U>&nbsp;5.01</U> of the Disclosure Letter, the Company (i)&nbsp;will conduct its operations according to its ordinary
course of business consistent with past practice and in compliance with all applicable Laws and the requirements of all Material Contracts, and will use its commercially reasonable efforts to preserve intact its business organization, keep available
the services of its current officers and employees and preserve the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
present relationships and goodwill with all material suppliers, any Governmental Entity and any Person having significant business relationships with the Company, and (ii)&nbsp;without limiting
the generality of the foregoing, will not: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;issue, sell, grant options or rights to purchase or receive,
pledge, or authorize or propose the issuance, sale, grant of options or rights to purchase or pledge, any Company Securities or any other right the value of which is in any way based on or derived from the value of any Company Securities, other than
Shares issuable upon exercise of the Company Options or Company Warrants or vesting of Restricted Stock Units outstanding on the date hereof in accordance with their terms; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;except as required by applicable Law, establish, adopt, terminate or amend any Company Stock Plan, or amend or
waive any of its rights under, or accelerate the vesting under, any provision of any of the Company Stock Plans; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;enter into or amend any Plan or any management, employment, indemnification, severance, retention, transaction
bonus, change in control, consulting, relocation, repatriation or expatriation agreement or other Contract between the Company and any current or former officer or other employee, contractor, consultant or director of or to the Company that would be
a Plan if entered into or adopted after the date of this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;acquire or redeem, directly or indirectly,
or amend any Company Securities, other than in connection with the exercise of the Company Options or vesting of Restricted Stock Units, or satisfaction of any tax withholding in connection therewith, outstanding on the date hereof in accordance
with the terms of the Company Equity Plans; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;fail to use commercially reasonable efforts to keep in force
insurance policies or replacement or revised provisions regarding insurance coverage with respect to material assets, operations and activities of the Company as currently in effect; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;split, combine or reclassify any Company Security or declare, set aside, make or pay any dividend or distribution
(whether in cash, stock or property) on any Company Security; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;enter into any stockholder rights plan or
similar arrangement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;(i) make any acquisition or disposition or cause any acquisition or disposition to be
made, by means of a merger, consolidation, recapitalization or otherwise, of any business, assets or securities (other than any acquisition or disposition of assets in the ordinary course of business consistent with past practice) or any sale,
lease, encumbrance or other disposition of assets or securities of the Company or any third party, in each case involving the payment of consideration (including consideration in the form of assumption of liabilities) in excess of $1&nbsp;million or
the disposition of assets or securities with a fair market value in excess of $1&nbsp;million, except for purchases or sales of raw materials or inventory made in the ordinary course of business and consistent with past practice, (ii)&nbsp;adopt a
plan of complete or partial liquidation, dissolution, recapitalization or restructuring, (iii)&nbsp;enter into or terminate a Material Contract or amend any Material Contract in any material respect or waive, assign, grant any release or
relinquishment of any material rights or benefits under any Material Contract, (iv)&nbsp;other than with respect to immaterial Contracts, entered into or amended in the ordinary </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
course of business consistent with past practice for a term of less than twelve (12)&nbsp;months, enter into or amend any Contracts, including any Material Contract, to which the Company is a
party or by which the Company or any of its properties or assets is bound, with any supplier or contract manufacturing organization of the Company, or (v)&nbsp;form any Subsidiary, acquire any equity interest in any other Person or enter into any
joint venture, partnership, limited liability corporation or similar arrangement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;incur, guarantee, assume or
otherwise become liable or responsible for any long-term debt or short-term debt, except for short-term debt incurred in the ordinary course of business consistent with past practice to fund working capital requirements; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;assume, guarantee, endorse or otherwise become liable or responsible (whether directly, contingently or otherwise)
for the obligations of any other Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;make any loans, advances or capital contributions to, or investments
in, any other Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;change in any material respect, any financial accounting methods, principles or
practices used by it, except as required by GAAP or applicable Law; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;fail to establish, in the ordinary course
of business and consistent with its past practices, reserves adequate for the payment of all of the Company&#146;s material unpaid Taxes for the period from the date of this Agreement through the Effective Time; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;make or change any material Tax election, change any annual Tax accounting period, adopt or change any method of
Tax accounting, enter into any material closing agreement, extend the statute of limitations (or file any extension request) relating to material Taxes with any Governmental Entity, take any material position on a Tax Return inconsistent with a
position taken on a Tax Return previously filed, amend any material Tax Return, settle, compromise or enter into any closing agreement with respect to any material Tax claim or assessment, surrender any right to claim a material Tax refund, offset
or other material reduction in Tax liability, or enter into any Material Contract with or request any material ruling from any Governmental Entity relating to Taxes; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;amend or permit the adoption of any amendments to its certificate of incorporation (whether by merger,
consolidation or otherwise); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;grant any severance or termination pay (other than in accordance with the terms
of a Plan as in effect immediately prior to the date of this Agreement or as required by applicable Law), or grant any increases in, accelerate the vesting or funding of, or waive any rights with respect to any compensation or benefits payable to
its officers, directors, employees or consultants; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q)&nbsp;&nbsp;&nbsp;&nbsp;enter into any collective bargaining or similar labor
agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r)&nbsp;&nbsp;&nbsp;&nbsp;adopt, enter into, amend or terminate any Plan (other than as required by applicable Law); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s)&nbsp;&nbsp;&nbsp;&nbsp;incur any capital expenditure or any obligations, liabilities or
indebtedness in respect thereof, except for (i)&nbsp;those contemplated by the capital expenditure budget for the relevant fiscal year, which capital expenditure budget has been provided or made available to Parent prior to the date of this
Agreement and (ii)&nbsp;any unbudgeted capital expenditure, in an amount not to exceed in any year, in the aggregate, $1&nbsp;million; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t)&nbsp;&nbsp;&nbsp;&nbsp;settle (i)&nbsp;any suit, action, claim, proceeding or investigation that is disclosed in the Company SEC Reports
filed prior to the date hereof or (ii)&nbsp;any other suit, action, claim, proceeding or investigation other than a settlement solely for monetary damages (without any admission of liability or other adverse consequences or ongoing restrictions or
obligations on the Company, Parent, Purchaser or the Surviving Corporation) in excess of $1&nbsp;million individually or $3&nbsp;million in the aggregate; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u)&nbsp;&nbsp;&nbsp;&nbsp;commence any suit, action, claim, proceeding or investigation, except in connection with a breach of this Agreement
or any other agreements contemplated hereby; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;authorize any of, or commit, resolve or agree to take any of, the
foregoing actions described in this <U>Section</U><U></U><U>&nbsp;5.01</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, nothing contained in this Agreement shall give
to Parent or Purchaser, directly or indirectly, rights to control or direct the operations of the Company prior to the Effective Time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Solicitation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;For the purposes of this Agreement, &#147;<U>Acceptable Confidentiality Agreement</U>&#148; means any customary
confidentiality agreement that is executed prior to the date of this Agreement or, if executed thereafter, does not prohibit the Company from providing any information to Parent in accordance with this <U>Section</U><U></U><U>&nbsp;5.02</U> or
otherwise prohibit the Company from complying with its obligations under this <U>Section</U><U></U><U>&nbsp;5.02</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as permitted by this <U>Section</U><U></U><U>&nbsp;5.02</U>, until the earlier of the Offer Acceptance Time
and the termination of this Agreement, the Company shall not, and shall direct and use reasonable best efforts to cause its Representatives not to, (i)&nbsp;continue any solicitation, knowing encouragement, or negotiations with any Persons that may
be ongoing with respect to an Acquisition Proposal, (ii)&nbsp;solicit, initiate or knowingly facilitate or knowingly encourage any inquiries regarding, or the making of any proposal or offer that constitutes, or could reasonably be expected to lead
to, an Acquisition Proposal, (iii)&nbsp;engage in, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any other Person any material <FONT STYLE="white-space:nowrap">non-public</FONT> information for the
purpose of soliciting, knowingly encouraging or knowingly facilitating, an Acquisition Proposal or any proposal or offer that could reasonably be expected to lead to an Acquisition Proposal, or (iv)&nbsp;enter into any letter of intent, acquisition
agreement, agreement in principle or similar agreement with respect to an Acquisition Proposal or any proposal or offer that could reasonably be expected to lead to an Acquisition Proposal. Within five (5)&nbsp;days from the date of this Agreement,
the Company shall, and shall direct its Representatives to, request the return or destruction of all material <FONT STYLE="white-space:nowrap">non-public</FONT> information provided to third parties prior to the date of this Agreement that have,
within the twelve </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(12)&nbsp;month period preceding the date of this Agreement, entered into confidentiality agreements relating to a possible Acquisition Proposal and immediately terminate access by any third
party to any data room (virtual or actual) containing any of the Company&#146;s material <FONT STYLE="white-space:nowrap">non-public</FONT> information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;If at any time on or after the date of this Agreement and prior to the Offer Acceptance Time the Company or any of
its Representatives receives a <I>bona</I><I></I><I>&nbsp;fide</I> written Acquisition Proposal from any Person or group of Persons, which Acquisition Proposal was made or renewed on or after the date of this Agreement and did not result from any
breach of this <U>Section</U><U></U><U>&nbsp;5.02</U>, (i)&nbsp;the Company and its Representatives may contact such Person or group of Persons to clarify the terms and conditions thereof and (ii)&nbsp;if the Company Board determines in good faith,
after consultation with financial advisors and outside legal counsel, that such Acquisition Proposal constitutes or could reasonably be expected to lead to a Superior Proposal, then the Company and its Representatives may (x)&nbsp;furnish, pursuant
to an Acceptable Confidentiality Agreement, information (including material <FONT STYLE="white-space:nowrap">non-public</FONT> information) with respect to the Company to the Person or group of Persons who has made such Acquisition Proposal and
(y)&nbsp;engage in or otherwise participate in discussions or negotiations with the Person or group of Persons making such Acquisition Proposal; <U>provided</U>, that the Company shall concurrently provide to Parent any material <FONT
STYLE="white-space:nowrap">non-public</FONT> information concerning the Company that is provided to any Person given such access, which was not previously provided to Parent or its Representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Following the date of this Agreement, the Company shall (i)&nbsp;promptly (and in any event within forty-eight
(48)&nbsp;hours after an executive officer or director of the Company obtaining knowledge of receipt) notify Parent if any inquiries, proposals or offers with respect to an Acquisition Proposal are received by the Company or any of its
Representatives, (ii)&nbsp;with respect to an Acquisition Proposal, provide its material terms and conditions (redacted as to conceal the identity of the Person or group making the Acquisition Proposal), and (iii)&nbsp;keep Parent reasonably
informed of the status of (including changes to any material terms of, and any other material developments with respect to) such Acquisition Proposal on a prompt basis. Without limiting the foregoing, the Company shall promptly (and in any event
within twenty-four (24)&nbsp;hours after any determination) advise Parent in writing if the Company Board determines to begin providing information or engaging in discussions or negotiations concerning an Acquisition Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Nothing in this <U>Section</U><U></U><U>&nbsp;5.02</U> or elsewhere in this Agreement shall prohibit the Company
from (i)&nbsp;taking and disclosing to the Company Stockholders a position contemplated by <FONT STYLE="white-space:nowrap">Rule&nbsp;14e-2(a),</FONT> <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-9</FONT> or Item&nbsp;1012(a) of Regulation <FONT
STYLE="white-space:nowrap">M-A</FONT> promulgated under the Exchange Act, (ii)&nbsp;making any disclosure to the Company Stockholders that the Company determines is required by applicable Laws or (iii)&nbsp;making any &#147;stop, look and
listen&#148; communication pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-9(f)</FONT> promulgated under the Exchange Act; <I>provided</I>, <I>that</I> this <U>Section</U><U></U><U>&nbsp;5.02</U> shall not be deemed to permit the Company
Board to make an Adverse Recommendation Change except to the extent permitted by <U>Section</U><U></U><U>&nbsp;5.02(f)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;The Company hereby consents to the Offer and represents that the Company Board, at a meeting duly called and held,
has made the Company Board Recommendation. Subject to this <U>Section</U><U></U><U>&nbsp;5.02</U>, the Company hereby consents to the inclusion of a description of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company Board Recommendation in the Offer Documents. Except as provided below, neither the Company nor the Company Board shall (i)&nbsp;(A)&nbsp;change, qualify, withhold, withdraw or modify, or
authorize or publicly propose to change, qualify, withhold, withdraw or modify, in a manner adverse to Parent, the Company Board Recommendation, (B)&nbsp;make, or publicly propose to make, any recommendation in connection with a tender offer or
exchange offer other than a recommendation against such offer or a customary &#147;stop, look and listen&#148; communication by the Company Board of the type contemplated by <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-9(f)</FONT> under the
Exchange Act, (D)&nbsp;fail to recommend against an Acquisition Proposal within five (5)&nbsp;Business Days after a request by Parent to do so or (E)&nbsp;resolve, agree or publicly propose to take any such actions (each such action set forth in
clause&nbsp;(i) being referred to herein as an &#147;<U>Adverse Recommendation Change</U>&#148;) or (ii)&nbsp;authorize, approve, recommend or publicly propose to, or cause or permit the Company to, enter into any letter of intent, agreement in
principle, acquisition agreement or any other agreement (other than an Acceptable Confidentiality Agreement) related to any Acquisition Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary contained in this Agreement, at any time prior to the Offer Acceptance Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;if the Company has received a <I>bona</I><I></I><I>&nbsp;fide</I> written Acquisition Proposal that
did not result from, directly or indirectly, a breach of this <U>Section</U><U></U><U>&nbsp;5.02</U> from any Person that has not been withdrawn and, after consultation with outside legal counsel and its financial advisors, the Company Board shall
have determined, in good faith, that such Acquisition Proposal is a Superior Proposal, (x)&nbsp;the Company Board may make an Adverse Recommendation Change, or (y)&nbsp;the Company may terminate this Agreement to enter into a binding written
definitive acquisition agreement providing for the consummation of a transaction constituting a Superior Proposal (a &#147;<U>Specified Agreement</U>&#148;), with respect to such Superior Proposal, in each case if and only if: (a)&nbsp;the Company
Board determines in good faith, after consultation with the Company&#146;s outside legal counsel, that the failure to do so would reasonably be expected to be inconsistent with the fiduciary duties of the Company Board to the Company Stockholders
under applicable Laws; (b)&nbsp;the Company shall have given Parent prior written notice of its intention to consider making an Adverse Recommendation Change or terminating this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;7.01(c)(ii)</U> at
least three (3)&nbsp;Business Days prior to making any such Adverse Recommendation Change or termination (a &#147;<U>Determination Notice</U>&#148;) (which notice shall not constitute an Adverse Recommendation Change or termination); and (c)(1) the
Company shall have provided to Parent the material terms and conditions of the Acquisition Proposal and the identity of the Person making the Acquisition Proposal), (2)&nbsp;the Company shall have given Parent the three (3)&nbsp;Business Days after
the Determination Notice to propose revisions to the terms of this Agreement or make another proposal so that such Acquisition Proposal would cease to constitute a Superior Proposal, and shall have negotiated in good faith with Parent (to the extent
Parent desires to negotiate) with respect to such proposed revisions or other proposal, if any, and (3)&nbsp;after considering the results of such negotiations and giving effect to the proposals made by Parent, if any, after consultation with
outside legal counsel and its financial advisors, the Company Board shall have determined, in good faith, that such Acquisition Proposal is a Superior Proposal and that the failure to make an Adverse Recommendation Change or terminate this Agreement
pursuant to <U>Section</U><U></U><U>&nbsp;7.01(c)(ii)</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
would reasonably be expected to be inconsistent with the fiduciary duties of the Company Board to the Company Stockholders under applicable Laws. Issuance of any &#147;stop, look and listen&#148;
communication by or on behalf of the Company pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-9(f),</FONT> in compliance with <U>Section</U><U></U><U>&nbsp;5.02(e)</U>, shall not be considered an Adverse Recommendation Change and shall not
require the giving of a Determination Notice or compliance with the procedures set forth in this <U>Section</U><U></U><U>&nbsp;5.02(f)</U>. For the avoidance of doubt, the provisions of this <U>Section</U><U></U><U>&nbsp;5.02(f)(A)</U> shall also
apply to any material amendment to any Acquisition Proposal and require a new Determination Notice, except that the references to three (3)&nbsp;Business Days shall be deemed to be two (2)&nbsp;Business Days; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;other than in connection with an Acquisition Proposal, the Company Board may make an Adverse
Recommendation Change in response to an Intervening Event, if and only if: (a)&nbsp;the Company Board determines in good faith, after consultation with the Company&#146;s outside legal counsel, that the failure to do so would reasonably be expected
to be inconsistent with the fiduciary duties of the Company Board to the Company stockholders under applicable Laws; (b)&nbsp;the Company shall have given Parent a Determination Notice at least three (3)&nbsp;Business Days prior to making any such
Adverse Recommendation Change; and (c)&nbsp;(1)&nbsp;the Company shall have specified the Intervening Event in reasonable detail, (2)&nbsp;the Company shall have given Parent the three (3)&nbsp;Business Days after the Determination Notice to propose
revisions to the terms of this Agreement or make another proposal so that such Intervening Event would no longer necessitate an Adverse Recommendation Change, and shall have made its Representatives reasonably available to negotiate in good faith
with Parent (to the extent Parent desires to do so) with respect to such proposed revisions or other proposal, if any, and (3)&nbsp;after considering the results of such negotiations and giving effect to the proposals made by Parent, if any, after
consultation with outside legal counsel, the Company Board shall have determined, in good faith, that the failure to make the Adverse Recommendation Change in response to such Intervening Event would reasonably be expected to be inconsistent with
the fiduciary duties of the Company Board to the Company Stockholders under applicable Laws. For the avoidance of doubt, the provisions of this <U>Section</U><U></U><U>&nbsp;5.02(f)(B)</U> shall also apply to any material change to the facts and
circumstances relating to such Intervening Event and require a new Determination Notice, except that the references to three (3)&nbsp;Business Days shall be deemed to be two (2)&nbsp;Business Days. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03.&nbsp;&nbsp;&nbsp;&nbsp;<U>Access to Information</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;From and after the date of this Agreement until the earlier of the Effective Time or the termination of this
Agreement in accordance with its terms, the Company will (i)&nbsp;give Parent and Purchaser and their authorized Representatives reasonable access (during regular business hours upon reasonable notice) to such employees, offices, and other
facilities and to such books, contracts, commitments and records (including Tax Returns) of the Company as Parent may reasonably request and instruct the Company&#146;s independent public accountants to provide access to their work papers and such
other information as Parent or Purchaser may reasonably request, (ii)&nbsp;permit Parent and Purchaser to make such inspections as they may reasonably require, (iii)&nbsp;furnish Parent and Purchaser with such financial and operating data and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other information with respect to the business, properties and personnel of the Company as Parent or Purchaser may from time to time reasonably request and (iv)&nbsp;furnish promptly to Parent
and Purchaser a copy of each report, schedule and other document filed or received by the Company during such period pursuant to the requirements of the federal or state securities Laws, provided, however, that the foregoing shall not require the
Company to disclose or provide access to the extent that such disclosure or access in the Company&#146;s judgment (A)&nbsp;contravenes applicable Law, (B)&nbsp;causes a waiver of an attorney-client privilege or other privilege or loss of attorney
work product protection, (C)&nbsp;violates a confidentiality obligation to any Person or (D)&nbsp;interferes unreasonably with the business and operations of the Company. Notwithstanding the foregoing, the Company shall use commercially reasonable
efforts from and after the date of this Agreement until the earlier of the Effective Time or the termination of this Agreement in accordance with its terms to make appropriate substitute arrangements to permit reasonable disclosure not in violation
of such Laws, agreements or duty and information shall be disclosed subject to execution of a joint defense agreement in customary form, and disclosure may be limited to external counsel for Parent, to the extent that the Company determines is
reasonably required for the purpose of complying with the HSR Act, the Sherman Act, the Clayton Act, the FTC Act or any Foreign Antitrust Law. No information or knowledge obtained by Parent in any investigation pursuant to this
<U>Section</U><U></U><U>&nbsp;5.03(a)</U> shall affect or be deemed to modify any representation or warranty made by the Company hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;All information obtained by Parent or Purchaser pursuant to <U>Section</U><U></U><U>&nbsp;5.03(a)</U> shall be
subject to the provisions of the Confidentiality Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04.&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices of Certain Events</U>.
The Company shall promptly notify Parent of </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;to the Knowledge of the Company, any written notice or other
communication from any Person alleging that the consent of such Person is or may be required in connection with or relating to the transactions contemplated by this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;any written notice or other communication from any Governmental Entity received by the Company in connection with
or relating to the transactions contemplated by this Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;any suits or proceedings commenced against
the Company that relate to the consummation of the transactions contemplated by this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U> that the delivery of any notice pursuant
to this <U>Section&nbsp;5.04</U> shall not limit or otherwise affect the remedies available hereunder to Parent. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05.&nbsp;&nbsp;&nbsp;&nbsp;<U>Reasonable Best Efforts</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the terms and conditions of this Agreement, each of the Company, Parent and Purchaser shall use its
reasonable best efforts to take, or cause to be taken, all actions that are necessary or advisable to consummate and make effective, in the most expeditious manner practicable, the Offer, the Merger and the other transactions contemplated by this
Agreement, including filing within ten (10)&nbsp;Business Days any required submissions under the HSR Act and using reasonable best efforts to accomplish the following: (i)&nbsp;filing any required submissions as soon as is reasonably practicable
under any Foreign Antitrust Law which Parent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
determines should be made, in each case, with respect to this Agreement, the Offer, the Merger and the other transactions contemplated hereby, (ii)&nbsp;furnishing information required in
connection with such submissions under the HSR Act or any Foreign Antitrust Law (including responding to any &#147;second request&#148; for additional information or documentary material under the HSR Act as promptly as reasonably practicable),
(iii)&nbsp;keeping the other parties reasonably informed with respect to the status of any such submissions under the HSR Act or any Foreign Antitrust Law, including with respect to: (A)&nbsp;the receipt of any
<FONT STYLE="white-space:nowrap">non-action,</FONT> action, clearance, consent, approval or waiver, (B)&nbsp;the expiration of any waiting period, (C)&nbsp;the commencement or proposed or threatened commencement of any investigation, administrative
or judicial action or proceeding or Legal Proceeding under the HSR Act, the Federal Trade Commission Act, as amended (the &#147;<U>FTC Act</U>&#148;), the Clayton Act of 1914, as amended (the &#147;<U>Clayton Act</U>&#148;), the Sherman Antitrust
Act of 1890, as amended (the &#147;<U>Sherman Act</U>&#148;) or any Foreign Antitrust Law and (D)&nbsp;the nature and status of any objections raised or proposed or threatened to be raised under the HSR Act, the FTC Act, the Clayton Act, the Sherman
Act or any Foreign Antitrust Law with respect to this Agreement, the Offer, the Merger or the other transactions contemplated hereby and (iv)&nbsp;obtaining all necessary actions or <FONT STYLE="white-space:nowrap">non-actions,</FONT> waivers,
consents, clearances and approvals from any Governmental Entity. The Company, Parent and Purchaser shall use their reasonable best efforts to cooperate with each other: (1)&nbsp;in promptly determining whether any filings are required to be or
should be made or consents, approvals, permits or authorizations are required to be or should be obtained under any other supranational, national, federal, state, foreign or local Law or regulation or whether any consents, approvals or waivers are
required to be or should be obtained from other parties to loan agreements or other Contracts material to the Company&#146;s business in connection with this Agreement, the Offer, the Merger or the consummation of the other transactions contemplated
hereby and (2)&nbsp;in promptly making any such filings, furnishing information required in connection therewith and seeking to obtain timely any such consents, permits, authorizations, approvals or waivers. Parent shall be responsible for all
filing fees in connection with the filings determined to be required by the parties under the HSR Act or any Foreign Antitrust Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company, on the one hand, and Parent and Purchaser, on the other hand, shall: (i)&nbsp;promptly notify each
other party of, and if in writing, furnish the others with copies of (or, in the case of oral communications, advise the others of the contents of) any communication to such Person from a Governmental Entity and permit the others to review and
discuss in advance (and to consider in good faith any comments made by the others in relation to) any proposed written communication to a Governmental Entity and (ii)&nbsp;keep each other party reasonably informed of any developments, requests for
meetings or discussions with any Governmental Entity in respect of any filings, investigation or inquiry concerning the Transactions. The Company, Parent and Purchaser agree not to participate in any meeting or discussion, either in person or by
telephone, with any Governmental Entity in connection with the proposed transaction unless it consults with the other party in advance and, to the extent not prohibited by such Governmental Entity or by Law, gives the other party the opportunity to
attend and participate where appropriate and advisable under the circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing,
Parent and Purchaser shall not be required to commit to or effect, by consent decree, hold-separate orders or similar arrangements, trust, or otherwise, conduct of business restrictions, or the sale or disposition of any assets or businesses in
order to avoid the entry of, or to effect the dissolution of or vacate or lift, any order, decree or ruling, that would otherwise have the effect of preventing or delaying the consummation of the Offer, the Merger and the other transactions
contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;In the event that any Legal Proceeding or other administrative or
judicial action is commenced challenging any of the transactions contemplated hereby and such Legal Proceeding or other action seeks to prevent, impede or delay the consummation of the Offer, the Merger or any other transaction contemplated by this
Agreement, the Company shall cooperate with Parent and Purchaser and use its best efforts if and as requested by Parent to contest and resist any such Legal Proceeding or other action and to have vacated, lifted, reversed or overturned any decree,
judgment, injunction or other order that may result from such litigation, whether temporary, preliminary or permanent, that is in effect and that prohibits, prevents or restricts consummation of the transactions contemplated by this Agreement;
<U>provided</U> that neither Parent nor Purchaser shall be required to contest or resist any such Legal Proceeding or other action or to seek to have vacated, lifted, reversed or overturned any decree, judgment, injunction or other order that may
result from such Legal Proceeding or other action, whether temporary, preliminary or permanent, that is in effect and that prohibits, prevents or restricts consummation of the transactions contemplated by this Agreement, nor shall Parent or
Purchaser be required to commence any Legal Proceeding or other action for the purpose of removing any impediment to consummation of the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06.&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification, Exculpation and Insurance</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Parent and Purchaser agree that all rights to indemnification, exculpation and advancement of expenses existing in
favor of the current or former directors, officers and employees of the Company (each an &#147;<U>Indemnified Person</U>&#148;) as provided in the Company&#146;s certificate of incorporation or bylaws or under any agreement filed as an exhibit to a
Company SEC Report filed at least two (2)&nbsp;Business Days prior to the date hereof or listed on <U>Section</U><U></U><U>&nbsp;3.17</U> of the Disclosure Letter, in each case, as in effect on the date hereof, for acts or omissions occurring prior
to or at the Effective Time shall be assumed and performed by the Surviving Corporation and shall continue in full force and effect for a period not less than six (6)&nbsp;years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;From and after the Effective Time, Parent will cause to be maintained in effect for a period of six (6)&nbsp;years
after the Effective Time, in respect of acts or omissions occurring prior to or at the Effective Time, the Company&#146;s current directors&#146; and officers&#146; liability insurance covering each Person currently covered by the Company&#146;s
directors&#146; and officers&#146; liability insurance policy for acts or omissions occurring prior to the Effective Time; <U>provided</U> that Parent may (i)&nbsp;substitute therefor policies of an insurance company the material terms of which,
including coverage and amount, are no less favorable in any material respect to such directors and officers than the Company&#146;s existing policies as of the date hereof or (ii)&nbsp;request that the Company obtain such extended reporting period
coverage under its existing insurance programs (to be effective as of the Effective Time); and <U>provided</U> <U>further</U> that in no event shall Parent or the Company be required to pay annual premiums for insurance under this
<U>Section</U><U></U><U>&nbsp;5.06(b)</U> in excess of 300% of the amount of the annual premiums paid by the Company in fiscal year 2017 for such purpose, it being understood that Parent shall nevertheless be obligated to provide as much coverage as
may be obtained for such 300% amount. Prior to the Effective Time, notwithstanding anything to the contrary in this Agreement, the Company may purchase a <FONT STYLE="white-space:nowrap">six-year</FONT> &#147;tail&#148; prepaid policy on the
directors&#146; and officers&#146; liability insurance policies on terms and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conditions no less advantageous than the directors&#146; and officers&#146; liability insurance policies. In the event that the Company purchases such a &#147;tail&#148; policy prior to the
Effective Time, Parent and the Surviving Corporation shall maintain such &#147;tail&#148; policy in full force and effect and continue to honor their respective obligations thereunder, in lieu of all other obligations of Parent and the Surviving
Corporation under the first sentence of this <U>Section</U><U></U><U>&nbsp;5.06(b)</U> for so long as such &#147;tail&#148; policy shall be maintained in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything herein to the contrary, if any Indemnified Person notifies the Surviving Corporation on or
prior to the sixth anniversary of the Effective Time that a claim, action, suit, proceeding or investigation (whether arising before, at or after the Effective Time) has been made against such Indemnified Person, the provisions of this
<U>Section</U><U></U><U>&nbsp;5.06</U> shall continue in effect until the final disposition of such claim, action, suit, proceeding or investigation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;This <U>Section</U><U></U><U>&nbsp;5.06</U> shall survive the acceptance of Company Shares for payment pursuant to
the Offer and the consummation of the Merger and is intended to benefit, and shall be enforceable by, the Indemnified Persons and their respective heirs and legal representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;In the event that the Surviving Corporation or Parent or any of their respective successors or assigns
(i)&nbsp;consolidates with or merges into any other Person and shall not be the continuing or surviving Person of such consolidation or merger or (ii)&nbsp;transfers or conveys all or substantially all of its properties and assets to any Person,
then, and in each such case, proper provision shall be made so that the successors and assigns of the Surviving Corporation or Parent, as the case may be, shall succeed to the obligations set forth in this <U>Section</U><U></U><U>&nbsp;5.06</U>.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.07.&nbsp;&nbsp;&nbsp;&nbsp;<U>Employee Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;From and after the Closing Date, Parent shall or shall cause the Surviving Corporation to assume, honor and fulfill
all of the Company&#146;s employment, retention, severance and change in control obligations in accordance with the terms of the applicable Plan as in effect immediately prior to the date of this Agreement. In addition, Parent agrees to cause the
Surviving Corporation to pay any earned but unpaid bonuses earned for 2017 in accordance with the Company&#146;s annual bonus Plan to the extent such amounts remain unpaid as of the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Following the Closing Date and for a period ending not earlier than December&nbsp;31, 2018, Parent shall or shall
cause the Surviving Corporation to provide or maintain for employees of the Company who continue in the employ of Parent, the Surviving Corporation or any of their respective Subsidiaries following the Closing Date (&#147;<U>Continuing
Employees</U>&#148;), a base salary or hourly wage, annual target cash bonus opportunity and employee benefits which, in the aggregate, are substantially comparable to those provided to the Continuing Employees immediately prior to Closing (other
than benefits pursuant to any equity compensation plan or defined benefit pension plan), in each case, subject to <U>Section</U><U></U><U>&nbsp;5.07(a)</U>. This <U>Section</U><U></U><U>&nbsp;5.07</U> shall not require Parent to maintain any
compensation arrangement or benefit plan for any period of time after Closing. No provision of this Agreement shall be construed as a guarantee of continued employment of any Continuing Employee and this Agreement shall not be construed so as to
prohibit Parent or any of its Subsidiaries from having the right to terminate the employment of any Continuing Employee, provided that any such termination is effected in accordance with applicable Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;From and after the Closing, Parent shall provide, or shall cause its
Subsidiaries to provide, each Continuing Employee full credit for purposes of eligibility to participate, vesting and accrual of severance benefits under any employee benefit plans or arrangements maintained by Parent or any of its Subsidiaries for
such Continuing Employee&#146;s service with the Company, and with any predecessor employer, to the same extent recognized by the Company, except (i)&nbsp;to the extent such credit would result in the duplication of benefits for the same period of
service and (ii)&nbsp;for any purpose under any sabbatical benefit provided by Parent or its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Parent shall use commercially reasonable efforts to (i)&nbsp;waive for each Continuing Employee and his or her
dependents, any waiting period provision, <FONT STYLE="white-space:nowrap">pre-existing</FONT> condition limitation, actively at work requirement or any other restriction that would prevent immediate or full participation under the health and
welfare plans of Parent or any of its Subsidiaries applicable to such Continuing Employee to the extent such waiting period, <FONT STYLE="white-space:nowrap">pre-existing</FONT> condition limitation, actively at work requirement or other restriction
would not have been applicable to such Continuing Employee under the terms of the welfare plans of the Company, (ii)&nbsp;waive any and all evidence of insurability requirements (including <FONT STYLE="white-space:nowrap">pre-existing</FONT>
condition limitations, exclusions, waiting periods and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">actively-at-work</FONT></FONT> requirements) with respect to such Continuing Employees to the extent such evidence of
insurability requirements were not applicable to the Continuing Employees under the Plans immediately prior to the Closing, and (iii)&nbsp;give full credit under the welfare plans of Parent and its Subsidiaries applicable to each Continuing Employee
and his or her dependents for all <FONT STYLE="white-space:nowrap">co-payments</FONT> and deductibles satisfied prior to the Closing in the same plan year as the Closing, and for any lifetime maximums, as if there had been a single continuous
employer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;If, and only if, requested by Parent at least five (5)&nbsp;days before the Closing Date, the
Company shall take (or cause to be taken) all actions necessary or appropriate to terminate, effective no later than the day immediately preceding the Closing Date, the Company&#146;s 401(k) Plan. If Parent so provides notice to the Company, the
Company shall deliver to Parent, prior to the Closing Date, evidence that the Company Board has validly adopted resolutions to terminate such Plan (the form and substance of which resolutions shall be subject to review and approval of Parent, which
approval shall not be unreasonably withheld, conditioned or delayed), effective no later than the date immediately preceding the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;No provision of this Agreement shall create any third-party beneficiary or other rights in any current or former
employee, director or other service provider of the Company in respect of any benefits that may be provided, directly or indirectly, under any Plan or benefit plan of Parent. Nothing herein, expressed or implied, is intended or shall be construed to
(i)&nbsp;constitute an amendment to any of the compensation and benefits plans maintained for or provided to Continuing Employees prior to or following the Effective Time, (ii)&nbsp;impede or limit Parent, the Company, the Surviving Corporation or
any of their Affiliates from amending or terminating any Plan or other plan, arrangement, policy or agreement following the Effective Time or (iii)&nbsp;confer upon or give to any Person (including for the avoidance of doubt any current or former
employees, labor unions, directors, or independent contractors of the Company, or on or after the Effective Time, the Surviving Corporation or any of its future Subsidiaries), other than the parties hereto and their respective permitted successors
and assigns, any legal or equitable or other rights or remedies under or by reason of any provision of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.08.&nbsp;&nbsp;&nbsp;&nbsp;<U>Takeover Laws</U>. If any Takeover Law may become,
or may purport to be, applicable to the transactions contemplated by this Agreement or the tender and support agreements, the Company and the members of its board of directors will grant such approvals and take such actions as are necessary so that
the transactions contemplated by this Agreement and the tender and support agreements may be consummated as promptly as practicable on the terms and conditions contemplated hereby and thereby and otherwise act to exclude the applicability of any
Takeover Laws and to assist in any challenge by Parent or Purchaser to the validity or applicability to the Merger or any other transaction contemplated by this Agreement of any Takeover Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.09.&nbsp;&nbsp;&nbsp;&nbsp;<U>Stockholder Litigation</U>. In the event that any stockholder litigation related to this
Agreement, the Merger or the other transactions contemplated hereby is brought against the Company and/or its directors, the Company shall promptly notify Parent of such litigation and shall keep Parent reasonably informed with respect to the status
thereof. The Company shall give Parent the right to review and comment on all material filings or responses to be made by the Company in connection with any such stockholder litigation, the right to participate (at Parent&#146;s expense) in
connection with any such stockholder litigation, and the right to consult on the settlement with respect to such stockholder litigation, and the Company will in good faith take such comments into account, and, no such settlement shall be agreed to
without Parent&#146;s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed with respect to any such settlement that would not alter the terms of the transactions contemplated by this Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Press Releases</U>. The parties agree that the initial press release to be issued with respect to
the transactions contemplated by this Agreement shall be in the form heretofore agreed to by the parties and thereafter Parent and the Company shall obtain prior written consent from each other before issuing any press release, having any
communication with the press (whether or not for attribution) or making any other public statement, or scheduling any press conference or conference call with investors or analysts, with respect to this Agreement or the transactions contemplated
hereby. Notwithstanding the foregoing each party may, without such consultation or consent, (a)&nbsp;make any such release or announcement as may be required by Law or the rules or regulations of any applicable U.S.&nbsp;or <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> securities exchange or regulatory or governmental body to which the relevant party is subject or submits, in which case the party required to make the release or announcement shall use its reasonable best
efforts to allow each other party reasonable time to comment on such release or announcement in advance of such issuance, it being understood that the final form and content of any such release or announcement, to the extent so required, shall be at
the final discretion of the disclosing party and (b)&nbsp;make any public statement in response to questions from the press, analysts, investors or those attending industry conferences, make internal announcements to employees and make disclosures
in Company SEC Reports, so long as such statements are consistent with previous press releases, public disclosures or public statements approved by the other party. The restrictions set forth in this <U>Section</U><U></U><U>&nbsp;5.10</U> shall not
apply to any release, announcement or disclosure made or proposed to be made by the Company with respect to an Acquisition Proposal, Superior Proposal, Intervening Event or Adverse Recommendation Change. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Rule</U><U></U><U><FONT STYLE="white-space:nowrap">&nbsp;16b-3</FONT></U>. Notwithstanding
anything herein to the contrary, prior to the Offer Acceptance Time, the Company shall be permitted to take such steps as may be necessary or appropriate to cause the transactions contemplated by this Agreement, including any disposition of Shares
(including derivative securities with respect to such Shares) resulting from the transactions contemplated by this Agreement by each individual who is or will be subject to the reporting requirements of Section&nbsp;16(a) of the Exchange Act with
respect to the Company, to be exempt under <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> promulgated under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Employee Communications</U>. Prior to the Closing Date, the Company shall not communicate (and
shall use its commercially reasonable best efforts to ensure that no employee or director of the Company so communicates) with any employee regarding post-Closing employee benefit plans and compensation matters, without the prior written approval of
Parent, which shall not be unreasonably withheld. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer Taxes</U>. Parent shall be liable
for any documentary, sales, use, registration, stamp, or other similar transfer Taxes payable by reason of the transactions contemplated by this Agreement (&#147;<U>Transfer Taxes</U>&#148;). Parent shall file any Tax Returns with respect to such
Transfer Taxes in the time and manner prescribed by Law. The Company shall cooperate with the preparation and filing of any such Tax Return with respect to such Transfer Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Rule</U><U></U><U><FONT STYLE="white-space:nowrap">&nbsp;14d-10</FONT> Matters</U>. Prior to the
Offer Acceptance Time and to the extent permitted by applicable Laws, the Compensation Committee of the Company Board, at a meeting duly called and held, will approve, as an &#147;employment compensation, severance or other employee benefit
arrangement&#148; within the meaning of <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-10(d)(2)</FONT> under the Exchange Act, each agreement, arrangement or understanding between Purchaser, the Company or their respective Affiliates and any of the
officers, directors or employees of the Company that are effective as of the Agreement Date or are entered into after the Agreement Date and prior to the Effective Time pursuant to which compensation is paid to such officer, director or employee and
will take all other action reasonably necessary to satisfy the requirements of the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> safe harbor set forth in <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-10(d)</FONT> (2)&nbsp;under the Exchange
Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15.&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Exchange Delisting; Deregistration</U>. Prior to the Closing Date, the Company
shall cooperate with Parent to take, or cause to be taken, all actions, and do or cause to be done all things, reasonably necessary, proper or advisable on its part under applicable laws and rules and policies of NASDAQ to enable the delisting by
the Surviving Corporation of the Shares from NASDAQ and the deregistration of the Shares under the Exchange Act as promptly as practicable after the Effective Time, and in any event no more than ten (10)&nbsp;days after the Closing Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDITIONS PRECEDENT TO THE MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Conditions to Each Party</U><U>&#146;</U><U>s Obligation To Effect the Merger</U>. The obligations of each party to effect the Merger shall
be subject to the satisfaction (or waiver by all parties to the extent permitted under applicable Law), at or prior to the Closing, of each of the following conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Injunctions or Legal Restraints; Illegality</U>. No temporary restraining order, preliminary
or permanent injunction or other order or decree issued by any court of competent jurisdiction or other legal restraint or prohibition shall be in effect, and no Law shall have been enacted, entered, promulgated or enforced by any Governmental
Entity that, in any such case, prohibits or makes illegal the consummation of the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.02.&nbsp;&nbsp;&nbsp;&nbsp;<U>Consummation of Offer</U>. Purchaser (or Parent on Purchaser&#146;s behalf) shall have accepted
for payment or have caused to be accepted for payment and paid for all of the Company Shares validly tendered pursuant to the Offer and not withdrawn. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION, AMENDMENT AND WAIVER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>. This Agreement may be terminated and the Offer and Merger may be abandoned at
any time prior to the Effective Time (with any termination by Parent also being an effective termination by Purchaser): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;by mutual written consent of the Company and Parent; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;by either the Company or Parent at any time prior to the Offer Acceptance Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;if the Offer Acceptance Time shall not have occurred on or before June&nbsp;21, 2018 (the
&#147;<U>Outside Date</U>&#148;); <U>provided</U>, <U>however</U>, that (A)&nbsp;the right to terminate under this <U>Section</U><U></U><U>&nbsp;7.01(b)(i)</U> shall not be available to any party whose failure to fulfill in any material respect any
covenants and agreements of such party set forth in this Agreement has been the primary cause of, or the primary factor that resulted in, the failure of the Offer Acceptance Time to occur on or before the Outside Date and (B)&nbsp;the Company or
Parent may extend the Outside Date to a date no later than September&nbsp;21, 2018 solely with respect to obtaining the necessary regulatory approvals pursuant to the HSR Act or any other applicable Foreign Antitrust Law; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;if any court of competent jurisdiction or other Governmental Entity with competent jurisdiction
shall have issued an order, decree or ruling, or taken any other action restraining, enjoining or otherwise prohibiting the acceptance for payment of Company Shares pursuant to the Offer or the Merger or making consummation of the Offer or the
Merger illegal and such order, decree, ruling or other action shall have become final and <FONT STYLE="white-space:nowrap">non-appealable;</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;by the Company at any time prior to the Offer Acceptance Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;if Parent or Purchaser shall have breached or failed to perform any of its covenants or agreements
set forth in this Agreement, or if any representation or warranty of Parent or Purchaser shall have become untrue, which breach or failure to perform or to be true, either individually or in the aggregate, if occurring or continuing at the Offer
Acceptance Time (A)&nbsp;would reasonably be expected, individually or in the aggregate, to prevent, materially impede or materially delay the consummation of the Transactions and (B)&nbsp;cannot be or has not been cured by the earlier of
(1)&nbsp;the Outside Date and (2)&nbsp;thirty (30)&nbsp;days after the giving of written notice to Parent of such breach or failure; <U>provided</U> that the Company shall not have the right to terminate this Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;7.01(c)(i)</U> if it is then in breach of any of its representations, warranties, covenants or agreements set forth in this Agreement such that the conditions set forth in clauses (b)&nbsp;or (c) of Annex I would not be
satisfied; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;in order to accept a Superior Proposal and enter into a Specified Agreement,
subject to the prior or concurrent payment of the Termination Fee as provided in <U>Section</U><U></U><U>&nbsp;7.03</U>; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;by Parent at any time prior to the Offer Acceptance Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;if the Company shall have breached or failed to perform any of its covenants or agreements set forth
in this Agreement, or if any representation or warranty of the Company shall have become untrue, which breach or failure to perform or to be true, either individually or in the aggregate, if occurring or continuing at the Effective Time
(A)&nbsp;would result in the failure of any of the conditions set forth in clauses (b)&nbsp;or (c) of Annex I and (B)&nbsp;cannot be or has not been cured by the earlier of (1)&nbsp;the Outside Date and (2)&nbsp;thirty (30)&nbsp;days after the
giving of written notice to the Company of such breach or failure; <U>provided</U> that Parent shall not have the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;7.01(d)(i)</U> if Parent or Purchaser is then in
breach of any of its representations, warranties, covenants or agreements set forth in this Agreement that would reasonably be expected, individually or in the aggregate, to prevent, materially impede or materially delay the consummation of the
Transactions; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;if, prior to the Offer Acceptance Time, (A)&nbsp;an Adverse Recommendation
Change shall have occurred, (B)&nbsp;the Company Board shall have formally resolved to make an Adverse Recommendation Change or (C)&nbsp;the Company Board shall have failed to include the Company Board Recommendation in the Schedule <FONT
STYLE="white-space:nowrap">14D-9</FONT> when mailed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The party desiring to terminate this Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;7.01</U> (other than clause&nbsp;(a) thereof) shall give written notice of termination to the other party in accordance with <U>Section</U><U></U><U>&nbsp;8.05</U>, specifying the provision or provisions hereof pursuant
to which such termination is effected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.02.&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect of Termination</U>. If this Agreement is
terminated and the Offer and Merger is abandoned pursuant to <U>Section</U><U></U><U>&nbsp;7.01</U>, this Agreement shall immediately become void and have no effect, without any liability on the part of any party, <U>provided</U> however, that
(a)&nbsp;the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Confidentiality Agreement and the provisions of <U>Section</U><U></U><U>&nbsp;5.03(b)</U> (Access to Information), <U>Section</U><U></U><U>&nbsp;5.10</U> (Press Releases), this
<U>Section</U><U></U><U>&nbsp;7.02</U>, <U>Section</U><U></U><U>&nbsp;7.03</U> (Fees and Expenses) and <U>Article</U><U></U><U>&nbsp;VIII</U> (General Provisions) shall survive the termination hereof; (b)&nbsp;no such termination shall relieve any
party from any liability for common law fraud or Willful and Material Breach of this Agreement prior to the date of termination, in which case the <FONT STYLE="white-space:nowrap">non-breaching</FONT> party shall be entitled to all rights and
remedies available at law or in equity; (c)&nbsp;no termination of this Agreement shall in any way affect any of the parties&#146; rights or obligations with respect to any shares of Company Common Stock accepted for payment pursuant to the Offer
prior to such termination. Nothing shall limit or prevent any party from exercising any rights or remedies it may have under <U>Section</U><U></U><U>&nbsp;8.03</U> in lieu of terminating this Agreement pursuant to
<U>Section</U><U></U><U>&nbsp;7.01</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.03.&nbsp;&nbsp;&nbsp;&nbsp;<U>Fees and Expenses</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided in this <U>Section</U><U></U><U>&nbsp;7.03</U>, all fees and expenses incurred in
connection with this Agreement, the Offer, the Merger and the other transactions contemplated hereby shall be paid by the party incurring such fees or expenses, whether or not the Offer or Merger are consummated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the event that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;(A) an Acquisition Proposal is publicly disclosed and is not withdrawn (in the case of a termination
pursuant to <U>Section</U><U></U><U>&nbsp;7.01(b)(i)</U> or <U>Section</U><U></U><U>&nbsp;7.01(d)(i)</U>, prior to such termination), (B)&nbsp;this Agreement is terminated by Parent or the Company pursuant to
<U>Section</U><U></U><U>&nbsp;7.01(b)(i)</U> or by Parent pursuant to <U>Section</U><U></U><U>&nbsp;7.01(d)(i)</U>, and (C)&nbsp;within nine (9)&nbsp;months after the date of such termination, the Company enters into a definitive agreement with a
third party with respect to an Acquisition Transaction and such Acquisition Transaction is consummated, or consummates a transaction that constitutes an Acquisition Transaction with a third party (provided, however, that for purposes of this
Section&nbsp;7.03(b)(i), each reference to &#147;twenty percent (20%)&#148; or &#147;eighty percent (80%)&#148; in the definition of &#147;Acquisition Transaction&#148; shall be deemed to be a reference to &#147;fifty percent (50%)&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;this Agreement is terminated by Parent pursuant to <U>Section</U><U></U><U>&nbsp;7.01(d)(ii)</U>;
or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;this Agreement is terminated by the Company pursuant to
<U>Section</U><U></U><U>&nbsp;7.01(c)(ii)</U>, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;then, in any such event, the Company shall pay
to Parent a fee of $58,000,000 (the &#147;<U>Termination Fee</U>&#148;), <U>less</U> the amount of Parent Expenses previously paid to Parent (if any) pursuant to <U>Section</U><U></U><U>&nbsp;7.03(c)</U>, it being understood that in no event shall
the Company be required to pay the Termination Fee on more than one occasion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;In the event that this Agreement
is terminated by the Company or Parent pursuant to <U>Section</U><U></U><U>&nbsp;7.01(b)(ii)</U> under circumstances in which the Termination Fee is not then payable pursuant to <U>Section</U><U></U><U>&nbsp;7.03(b)(i)</U>, then the Company shall
reimburse Parent and its Affiliates for all of their reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees and expenses (including all fees and expenses of counsel, accountants, investment
bankers, experts and consultants to Parent and Purchaser and their Affiliates) incurred by Parent or Purchaser or on their behalf in connection with or related to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
authorization, preparation, investigation, negotiation, execution and performance of this Agreement and the transactions contemplated hereby (the &#147;<U>Parent Expenses</U>&#148;), up to a
maximum amount of $9,680,000; <U>provided</U> that the payment by the Company of the Parent Expenses pursuant to this <U>Section</U><U></U><U>&nbsp;7.03(c)</U>, shall not relieve the Company of any subsequent obligation to pay the Termination Fee
pursuant to <U>Section</U><U></U><U>&nbsp;7.03(b)</U> except to the extent indicated in such Section. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Payment
of the Termination Fee shall be made by wire transfer of same day funds to the accounts designated by Parent (i)&nbsp;on the consummation of any transaction contemplated by an Acquisition Proposal, in the case of a Termination Fee payable pursuant
to <U>Section</U><U></U><U>&nbsp;7.03(b)(i)</U>, (ii)&nbsp;as promptly as reasonably practicable after termination (and, in any event, within two (2)&nbsp;Business Days thereof), in the case of a Termination Fee payable pursuant to
<U>Section</U><U></U><U>&nbsp;7.03(b)(ii)</U> or (iii)&nbsp;concurrently with, and as a condition to the effectiveness of, termination of this Agreement in the case of a Termination Fee payable pursuant to
<U>Section</U><U></U><U>&nbsp;7.03(b)(iii)</U>. Payment of the Parent Expenses shall be made by wire transfer of same day funds to the accounts designated by Parent within two (2)&nbsp;Business Days after the Company&#146;s having been notified of
the amounts thereof by Parent and delivery to the Company of documentation (reasonably satisfactory to the Company) substantiating such fees and expenses. In the event that Parent or its designee shall receive payment pursuant to this
<U>Section</U><U></U><U>&nbsp;7.03(d)</U>, the receipt of the Termination Fee shall be deemed to be liquidated damages for any and all losses or damages suffered or incurred by Parent, Purchaser or any of their respective Affiliates or any other
Person in connection with this Agreement (and the termination hereof), the Offer and the Merger (and the abandonment thereof) or any matter forming the basis for such termination, and none of Parent, Purchaser, any of their respective Affiliates or
any other Person shall be entitled to bring or maintain any claim, action or proceeding against the Company or any of its Affiliates arising out of or in connection with this Agreement, the Offer, the Merger or any matters forming the basis for such
termination; <U>provided</U><I>, </I>however, that payment of the Termination Fee will not be liquidated damages in the case of common law fraud or a Willful and Material Breach of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Company acknowledges that the agreements contained in this <U>Section</U><U></U><U>&nbsp;7.03</U> are an
integral part of the transactions contemplated by this Agreement and constitute liquidated damages and not a penalty, and that, without these agreements, the parties would not have entered into this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.04.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment or Supplement</U>. This Agreement may be amended, modified or supplemented by the
consent of all parties by action taken or authorized by their respective boards of directors at any time prior to the Offer Acceptance Time; <U>provided</U>, <U>however</U>, that after the Offer Acceptance Time, no amendment shall be made that
pursuant to applicable Law requires further approval or adoption by the Company Stockholders without such further approval or adoption. This Agreement may not be amended, modified or supplemented in any manner, whether by course of conduct or
otherwise, except by an instrument in writing specifically designated as an amendment hereto, signed on behalf of each of the parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.05.&nbsp;&nbsp;&nbsp;&nbsp;<U>Extension of Time; Waiver</U>. At any time prior to the Offer Acceptance Time, (a)&nbsp;the
Company may, by action taken or authorized by the Company Board, to the extent permitted by applicable Law, (i)&nbsp;extend the time for the performance of any of the obligations or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
acts of Parent or Purchaser, (ii)&nbsp;waive any inaccuracies in the representations and warranties of Parent or Purchaser set forth in this Agreement or any document delivered pursuant hereto or
(iii)&nbsp;subject to applicable Law, waive compliance with any of the covenants, agreements or conditions of Parent or Purchaser contained herein, and (b)&nbsp;Parent and Purchaser may, by action taken or authorized by their respective boards of
directors, to the extent permitted by applicable Law, (i)&nbsp;extend the time for the performance of any of the obligations or acts of the Company, (ii)&nbsp;waive any inaccuracies in the representations and warranties of the Company set forth in
this Agreement or any document delivered pursuant hereto or (iii)&nbsp;subject to applicable Law, waive compliance with any of the covenants, agreements or conditions of the Company contained herein; <U>provided</U>, <U>however</U>, that after the
Offer Acceptance Time, no waiver may be made that pursuant to applicable Law requires further approval or adoption by the Company Stockholders without such further approval or adoption. Any agreement on the part of a party to any such extension or
waiver shall be valid only if set forth in a written instrument executed and delivered by a duly authorized officer on behalf of such party. No failure or delay of any party in exercising any right or remedy hereunder shall operate as a waiver
thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of
any other right or power. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or remedies which they would otherwise have hereunder. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VIII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL PROVISIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.01.&nbsp;&nbsp;&nbsp;&nbsp;<U><FONT STYLE="white-space:nowrap">Non-Survival</FONT> of Representations and Warranties</U>. None
of the representations, warranties, covenants or agreements in this Agreement or in any schedule, instrument or other document delivered pursuant to this Agreement shall survive the Effective Time, other than those covenants or agreements of the
parties which by their terms apply, or are to be performed in whole or in part, after the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.02.&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement</U>. This Agreement and the exhibits and schedules hereto, the Disclosure Letter
and the Confidentiality Agreement constitutes the entire agreement with respect to the subject matter hereof and thereof, and supersede all prior written agreements, arrangements, communications and understandings and all prior and contemporaneous
oral agreements, arrangements, communications and understandings among the parties with respect to the subject matter hereof and thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.03.&nbsp;&nbsp;&nbsp;&nbsp;<U>Specific Performance</U>. The parties agree that irreparable damage would occur in the event that
any of the parties hereto do not perform the provisions of this Agreement in accordance with its terms or otherwise breach such provisions. Accordingly, prior to any termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;7.01</U>,
the parties acknowledge and agree that each party shall be entitled to obtain an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in the
Court of Chancery of the State of Delaware, <U>provided</U> that if jurisdiction is not then available in the Court of Chancery of the State of Delaware, then in any federal court located in the State of Delaware, this being in addition to any other
remedy to which such party is entitled at law or in equity. Each of the parties hereby further waives (a)&nbsp;any defense in any action for specific performance that a remedy at law would be adequate and (b)&nbsp;any requirement under any Law to
post security as a prerequisite to obtaining equitable relief. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.04.&nbsp;&nbsp;&nbsp;&nbsp;<U>Submission to Jurisdiction; Waiver of Jury
Trial</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Each of the parties irrevocably agrees that any legal action or proceeding arising out of or
relating to this Agreement brought by any party or its Affiliates against any other party or its Affiliates (whether in contract or tort, in law or in equity, or granted by statute or otherwise) shall be brought and determined in the Court of
Chancery of the State of Delaware, <U>provided</U> that, if jurisdiction is not then available in the Court of Chancery of the State of Delaware, then any such legal action or proceeding may be brought in any federal court located in the State of
Delaware. Each of the parties hereby irrevocably submits to the jurisdiction of such courts for itself and with respect to its property, generally and unconditionally, with regard to any such action or proceeding arising out of or relating to this
Agreement and the transactions contemplated hereby. Each of the parties agrees not to commence any action, suit or proceeding relating thereto except in the courts described above in Delaware, other than actions in any court of competent
jurisdiction to enforce any judgment, decree or award rendered by any such court in Delaware as described herein. Each of the parties further agrees that notice as provided herein shall constitute sufficient service of process and the parties
further waive any argument that such service is insufficient. Each of the parties hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any action or proceeding
arising out of or relating to this Agreement or the transactions contemplated hereby, (i)&nbsp;any claim that it is not personally subject to the jurisdiction of the courts in Delaware as described herein for any reason, (ii)&nbsp;that it or its
property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment
or otherwise) and (iii)&nbsp;that (A)&nbsp;the suit, action or proceeding in any such court is brought in an inconvenient forum, (B)&nbsp;the venue of such suit, action or proceeding is improper or (C)&nbsp;this Agreement, or the subject matter
hereof, may not be enforced in or by such courts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;EACH OF THE PARTIES TO THIS AGREEMENT HEREBY IRREVOCABLY
WAIVES ALL RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.05.&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. All notices and other communications hereunder shall be in writing and shall be
deemed to have been duly given and received (a)&nbsp;upon receipt, if delivered personally, (b)&nbsp;two (2)&nbsp;Business Days after deposit in the mail, if sent by registered or certified mail, (c)&nbsp;on the next Business Day after deposit with
an overnight courier, if sent by overnight courier, (d)&nbsp;upon transmission and confirmation of receipt, if sent by facsimile prior to 6:00&nbsp;p.m., local time, in the place of receipt or (e)&nbsp;on the next Business Day following transmission
and confirmation of receipt, if sent by facsimile or email transmission after 6:00&nbsp;p.m., local time, in the place of receipt; provided that the notice or other communication is sent to the address or facsimile number set forth beneath the name
of such party below (or to such other address or facsimile number as such party shall have specified in a written notice to the other parties): </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">if to Parent or Purchaser (or, following the Effective Time, the Company): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Roche Holdings, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">1 DNA Way
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">South San Francisco, CA 94080 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General Counsel </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Facsimile:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(650) <FONT STYLE="white-space:nowrap">225-6000</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">F. <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche Ltd </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Group Legal Department </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Grenzacherstrasse 124 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">CH-</FONT> 4070 Basel, Switzerland </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr.&nbsp;Beat
Kraehenmann </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Facsimile:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;+41 61 688 13 96 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">and to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Sidley Austin LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">555 California Street, Suite 2000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94104 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sharon R. Flanagan </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Facsimile:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(415) <FONT STYLE="white-space:nowrap">772-7400</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sflanagan@sidley.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">and to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Sidley Austin LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">1001 Page Mill Road </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Palo Alto,
CA 94304 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jennifer F. Fitchen </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Facsimile:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(650) <FONT STYLE="white-space:nowrap">565-7100</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;jfitchen@sidley.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">if to the Company (prior to the Effective Time): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Ignyta, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">4545 Towne Centre
Court </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">San Diego, CA 92121 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General Counsel </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">12670 High Bluff Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">San
Diego, CA 92130 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cheston J. Larson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Michael E. Sullivan </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Facsimile:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(858) <FONT STYLE="white-space:nowrap">523-5450</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cheston.larson@lw.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;michael.sullivan@lw.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">and to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp;
Watkins LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">885 Third Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">New York, NY 10022 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Attention:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Charles K. Ruck </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Facsimile:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(212) <FONT STYLE="white-space:nowrap">751-4864</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Email:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;charles.ruck@lw.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address as the Person to whom notice is given may have previously furnished to the others in writing in the manner set forth above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.06.&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law</U>. This Agreement and the exhibits and schedules hereto, and any dispute, claims
or causes of action (whether in contract, tort or statute) arising out of, relating to or in connection with this Agreement, or the negotiation, execution or performance thereof, shall be governed by and construed and enforced in accordance with the
Laws of the State of Delaware, without giving effect to any choice or conflict of Law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the
State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.07.&nbsp;&nbsp;&nbsp;&nbsp;<U>Assignment; Successors</U>. Neither this Agreement nor any of the rights,
interests or obligations under this Agreement may be assigned or delegated, in whole or in part, by operation of law, by merger or otherwise, by any party without the prior written consent of the other parties, and any such assignment without such
prior written consent shall be null and void; <U>provided</U>, that Parent or Purchaser may assign any of their respective rights and obligations to any direct or indirect Subsidiary of Parent, but no such assignment shall relieve Parent or
Purchaser, as the case may be, of its obligations hereunder. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of, and be enforceable by, the parties and their respective successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.08.&nbsp;&nbsp;&nbsp;&nbsp;<U>Parties in Interest</U>. This Agreement shall be binding upon and inure solely to the benefit of
each party hereto, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other Person other than the parties hereto and their respective successors and permitted assigns any rights or remedies of any nature
whatsoever under or by reason of this Agreement except for <U>Section</U><U></U><U>&nbsp;5.07</U> (which is intended to be for the benefit of the Persons referred to therein, and may be enforced by any such Persons). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.09.&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. If any term or other provision of
this Agreement is invalid, illegal or incapable of being enforced by any rule of Law, or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal
substance of the Transactions is not affected in any manner materially adverse to any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good
faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the Transactions be consummated as originally contemplated to the fullest extent possible. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts; Facsimile or.pdf Signature</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but all of which,
taken together, shall constitute one and the same agreement and shall become effective when one or more counterparts has been signed by each of the parties and delivered to the other parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;This Agreement may be executed by facsimile or.pdf signature and a facsimile or .pdf signature shall constitute an
original for all purposes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Defined Terms; Interpretation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement, the term: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Acquisition Proposal</U>&#148; shall mean any offer or proposal (other than an offer or
proposal by Parent or Purchaser), in each case, relating to any Acquisition Transaction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Acquisition Transaction</U>&#148; shall mean any transaction or series of related
transactions (other than the Transactions) involving: (i)&nbsp;any acquisition or purchase from the Company by any Person or &#147;group&#148; (as defined in or under Section&nbsp;13(d) of the Exchange Act), directly or indirectly, of more than a
twenty percent (20%)&nbsp;interest in the total outstanding voting securities of the Company; (ii)&nbsp;any tender offer (including self-tender) or exchange offer that if consummated would result in any Person or &#147;group&#148; (as defined in or
under Section&nbsp;13(d) of the Exchange Act) beneficially owning twenty percent (20%)&nbsp;or more of the total outstanding voting securities of the Company; (iii)&nbsp;any merger, consolidation, business combination, share exchange, issuance of
securities, acquisition of securities, reorganization, recapitalization or other similar transaction involving the Company, the business(es) of which, individually or in the aggregate, constitute more than twenty percent (20%) of the assets of the
Company, pursuant to which the Company Stockholders immediately preceding such transaction hold less than eighty percent (80%) of the voting equity interests in the surviving or resulting entity of such transaction or any parent entity thereof;
(iv)&nbsp;any sale, lease, exchange, transfer, exclusive license or disposition (in each case, other than in the ordinary course of business) of more than twenty percent (20%) of the assets of the Company (measured by the fair market value thereof);
or (v)&nbsp;any combination of the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Affiliate</U>&#148; and
&#147;<U>Associate</U>&#148; means, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under common control with such Person; <U>provided</U> that none of Chugai Pharmaceutical Co. Ltd., <FONT
STYLE="white-space:nowrap">1-1,</FONT> Nihonbashi-Muromachi <FONT STYLE="white-space:nowrap">2-chome,</FONT> <FONT STYLE="white-space:nowrap">Chuo-ku</FONT> Tokyo, <FONT STYLE="white-space:nowrap">103-8324,</FONT> Japan (&#147;<U>Chugai</U>&#148;),
Foundation Medicine, Inc., 150 Second Street, Cambridge, MA 02141, USA (&#147;<U>FMI</U>&#148;) or any of their respective subsidiaries shall be considered an Affiliate or Associate of Parent, unless Parent opts for such inclusion of Chugai and/or
FMI and their respective subsidiaries by giving written notice to the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Beneficial Ownership</U>&#148; has the meaning given to such term in <FONT
STYLE="white-space:nowrap">Rule&nbsp;13d-3</FONT> under the Exchange Act; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Business
Day</U>&#148; means a day, other than Saturday, Sunday or other day on which commercial banks in New York, New York or Basel, Switzerland are authorized or required by Law to close; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Shares</U>&#148; shall have the meaning set forth in the Recitals; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Confidentiality Agreement</U>&#148; means the confidentiality agreement dated
November&nbsp;28, 2017 between Parent and the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Contract</U>&#148; means any
written or oral legally binding bond, debenture, note, mortgage, indenture, guarantee, license, lease, purchase or sale order or other contract, commitment, agreement, instrument or obligation, including all amendments thereto, and including any of
the foregoing that has been terminated or has expired and has ongoing obligations or under which any liabilities of any kind may exist; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Intervening Event</U>&#148; shall mean any material event or development or material
change of circumstances with respect to the Company that (i)&nbsp;was neither known to the Company Board nor reasonably foreseeable as of or prior to the date of this Agreement and (ii)&nbsp;does not relate to (A)&nbsp;any Acquisition Proposal,
(B)&nbsp;any events, changes or circumstances relating to Parent, Purchaser or any of their Affiliates, or (C)&nbsp;clearance of the Merger under the HSR Act, the Sherman Act, the Clayton Act, the FTC Act or any applicable Foreign Antitrust Laws;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Knowledge</U>&#148; of the Company, with respect to any matter in question, shall mean
the actual knowledge of such matter by any of the executive officers or directors of the Company after due inquiry; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Loan Agreement</U>&#148; shall mean that certain Loan Agreement, dated as of June&nbsp;30,
2016, between and among the Company, Silicon Valley Bank, as collateral agent, and Silicon Valley Bank and Oxford Finance LLC, as lenders (as amended, restated, supplemented or otherwise modified from time to time); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Material Adverse Effect</U>&#148; means any occurrence, violation, inaccuracy, change,
event, effect or circumstance that, individually or in the aggregate, (A)&nbsp;is or would be reasonably likely to be, materially adverse to the business, assets, results of operations or financial condition of the Company, <U>provided</U> that none
of the following </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
occurrences, violations, inaccuracies, changes, events, effects or circumstances shall be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse
Effect: (1)&nbsp;changes in general economic conditions or securities or financial markets in general, (2)&nbsp;changes in Law, including the rules, regulations and administrative policies of the FDA, or GAAP, (3)&nbsp;general changes in the
pharmaceutical industry, (4)&nbsp;conditions arising out of any outbreak or escalation of hostilities or war (whether declared or not declared), act of terrorism, political conditions, weather conditions or other force majeure or similar events (or
the escalation or worsening thereof), (5)&nbsp;the announcement or pendency of the Offer, the Merger, this Agreement and the transactions contemplated hereby (including, for the avoidance of doubt, to the extent solely resulting from the
announcement or pendency of the Offer, the Merger, this Agreement or the transactions contemplated hereby, the impact on the relationships, contractual or otherwise, of the Company with its officers or other employees, customers, lenders, suppliers
or business partners), (6)&nbsp;any actions taken, or the failure to take action which Parent or Purchaser has expressly requested and which is not otherwise required by this Agreement, (7)&nbsp;the failure of the Company to meet any internal or
published projections, forecasts, estimates or projections or analysts&#146; expectations in respect of revenues, cash burn-rate, cash flow, earnings or other financial or operating measures for any period; <U>provided</U> that the exception in this
clause shall not prevent or otherwise affect a determination that any occurrence, violation, inaccuracy, change, event, effect or circumstance underlying such failure has resulted in, or contributed to, a Material Adverse Effect, (8)&nbsp;any change
in the Company&#146;s stock price or trading volume, in and of itself; <U>provided</U> that the exception in this clause shall not prevent or otherwise affect a determination that any occurrence, violation, inaccuracy, change, event, effect or
circumstance underlying such change has resulted in, or contributed to, a Material Adverse Effect, (9)&nbsp;the determination by, or the delay of a determination by, the FDA or any other Governmental Entity, or any other panel or advisory body
empowered or appointed thereby, with respect to the acceptance, filing, designation, approval, clearance, <FONT STYLE="white-space:nowrap">non-acceptance,</FONT> refusal to file, refusal to designate,
<FONT STYLE="white-space:nowrap">non-approval,</FONT> disapproval or non-clearance of any of the Company&#146;s products or product candidates, (10)&nbsp;FDA approval (or other clinical or regulatory developments), market entry or threatened market
entry of any product competitive with or related to any of the Company&#146;s products or product candidates or (11)&nbsp;any stockholder class action or derivative litigation commenced against the Company since the date of this Agreement and
arising from allegations of breach of fiduciary duty of the Company&#146;s directors relating to their approval of this Agreement or from allegations of false or misleading public disclosure by the Company with respect to this Agreement;
<U>provided</U>, <U>however</U>, that any occurrence, violation, inaccuracy, change, event, effect or circumstance set forth in clauses&nbsp;(1), (2), (3) and (4)&nbsp;shall be taken into account to the extent such occurrence, violation, inaccuracy,
change, event, effect or circumstance has a disproportionate adverse effect on the Company relative to other participants in the industry in which the Company operates, or (B)&nbsp;is or would be reasonably likely to prevent the Company from
consummating the Offer, the Merger or the transactions contemplated by this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Offer Acceptance Time</U>&#148; shall mean the first time as of which Purchaser accepts
any Company Shares for payment pursuant to the Offer; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Offer Commencement Date</U>&#148; shall
mean the date on which Purchaser commences the Offer, within the meaning of Rule <FONT STYLE="white-space:nowrap">14d-2</FONT> under the Exchange Act; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xv)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Person</U>&#148; means any individual, corporation, limited liability company,
partnership, association, trust, estate or other entity or organization, including a Governmental Entity; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Personal Information</U>&#148; means patient medical records, and all other information
and data generated in the collection, use, storage, sharing, transfer, disposition, protection and processing thereof in connection with any nonclinical, preclinical or clinical trials conducted with respect to any product candidate, drug or
compound that the Company is developing or seeking regulatory approval for as of the date of this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xvii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Representatives</U>&#148; means officers, directors, employees, attorneys, accountants,
investment bankers, consultants, agents, financial advisors, other advisors and other representatives; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xviii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Subsidiary</U>&#148; means, when used with reference to an entity, any other entity of
which securities or other ownership interests having ordinary voting power to elect a majority of the board of directors or other Persons performing similar functions, or a majority of the outstanding voting securities of which, are owned directly
or indirectly by such entity (including, in the case of Parent, Purchaser, but excluding Chugai and FMI); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xix)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Superior Proposal</U>&#148; means any unsolicited, bona&nbsp;fide, written Acquisition
Proposal that the Company Board determines, in its good faith judgment (after consultation with its financial advisors and its outside legal counsel) is reasonably likely to be consummated in accordance with its terms, taking into account all legal,
regulatory and financing aspects (including certainty of closing) of the proposal, the Person making the proposal and other aspects of the Acquisition Proposal that the Company Board deems relevant, and if consummated, would result in a transaction
that is more favorable from a financial point of view to the holders of Shares (in their capacity as such and after taking into account any adjustment to the terms and conditions of this Agreement or the Offer proposed by Parent in response to such
Acquisition Proposal in accordance with <U>Section</U><U></U><U>&nbsp;5.02(f)</U> than the Merger; <U>provided</U> that for purposes of the definition of &#147;<U>Superior Proposal</U>&#148;, the references to &#147;twenty percent (20%)&#148; in the
definition of Acquisition Proposal shall be deemed to be references to &#147;fifty percent (50%);&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xx)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Third Party Service Provider</U>&#148; means any Person acting for or otherwise on behalf
of the Company that may collect, store, process, analyze or otherwise have access to any nonclinical, preclinical or clinical trials data, patient medical records, or any Personal Information or confidential information of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxi)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Transactions</U>&#148; shall mean (i)&nbsp;the execution and delivery of the Agreement
and (ii)&nbsp;all of the Transactions, including the Offer and the Merger. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxii)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Willful and Material Breach</U>&#148; of a
Party means a material and willful breach that is a consequence of an act undertaken by such Party with the actual knowledge and intention that the taking of such act would, or would reasonably be expected to, cause a breach of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The following terms are defined elsewhere in this Agreement,&nbsp;as&nbsp;indicated&nbsp;below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="27%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Acceptable&nbsp;Confidentiality&nbsp;Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;5.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Adverse Recommendation Change</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;5.02(f)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Book-Entry Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.04(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Certificate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.04(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Certificate of Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.05</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Clayton Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;5.05(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.04</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Closing Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.05</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Code</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.05</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Common Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Company Board Recommendation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Company Disclosure Schedule</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.25</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Company Financial Advisors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.08</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Company IP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.15(l)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Company Option</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.03(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Company Registered Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Company SEC Reports</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.05(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Company Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.02(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Company Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Company Stock Plans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.03(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Company Stockholders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Company Warrants</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.02</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Continuing Employees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;5.07(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Determination Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;5.02(f)(A)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">DGCL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.03</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Disclosure Letter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Article&nbsp;III</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Dissenting Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.07</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Effective Time</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.05</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Eli Lilly</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.17(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Eli Lilly Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.17(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Environmental Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.14(c)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Environmental Permits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.14(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">ERISA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.09(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">ERISA Affiliate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.09(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Exchange Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.04</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Excluded Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Expiration Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.01(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Extension Deadline</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.01(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">FDA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.18(a)</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="27%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">FDA&nbsp;Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.18(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">FDA Permits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.18(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Foreign Antitrust Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.04</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">FTC Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;5.05(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">GAAP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.05(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Governmental Entity</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.04</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Governmental Patent Authority</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.15(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Hazardous Substances</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.14(c)(ii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">HSR Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.04</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Indemnified Person</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;5.06(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Initial Expiration Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.01(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.15(l)(ii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">LDTs</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.18(h)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Legal Proceedings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.10</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Lien</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.04</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Material Contract</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.17(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Measurement Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.03, Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Merger Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Multiemployer Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.09(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Offer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Offer Conditions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Offer Documents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.01(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Offer to Purchase</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Option Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.03(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Outside Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;7.01(b)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Parent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Parent Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;7.03(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Paying Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.04(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Payment Fund</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.04(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Payoff Amount</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.08</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Payoff Letter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.08</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Permits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Permitted Liens</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.04</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Plans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.09(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Preferred Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Purchaser</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Real Property Leases</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.16(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Release</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.14(c)(iii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Restricted Stock Unit</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.03(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">RSU Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.03(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Sarbanes-Oxley Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.05(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Schedule&nbsp;14D-9</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Schedule&nbsp;TO</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.01(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">SEC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Article&nbsp;III</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="27%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Securities&nbsp;Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.02(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Share</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Sherman Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;5.05(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Specified Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;5.02(f)(A)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Stockholder List Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Surviving Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;1.03, Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Takeover Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.23</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Tax</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.12(k)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Tax Return</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;3.12(k)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Termination Fee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;7.03(b)(iv)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Transfer Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;5.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Warrant Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Section&nbsp;2.02</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The words &#147;hereof,&#148; &#147;herein,&#148; &#147;hereby,&#148;
&#147;herewith&#148; and words of similar import shall, unless otherwise stated, be construed to refer to this Agreement as a whole and not to any particular provision of this Agreement, and article, section, paragraph and schedule references are to
the articles, sections, paragraphs and schedules of this Agreement unless otherwise specified. Whenever the words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148; are used in this Agreement they shall be deemed to be followed by
the words &#147;without limitation.&#148; The words describing the singular number shall include the plural and vice versa, words denoting either gender shall include both genders and words denoting natural persons shall include all Persons and vice
versa. The phrases &#147;the date of this Agreement&#148; or &#147;the date hereof&#148; and terms of similar import, shall be deemed to refer to the date set forth in the preamble to this Agreement. Any reference in this Agreement to a date or time
shall be deemed to be such date or time in New York City, unless otherwise specified. As used in this Agreement, references to &#147;ordinary course of business&#148; mean the ordinary and usual course of normal <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations of the Company consistent with past practice and custom (including, as applicable, with respect to quantity and frequency). References to &#147;Made Available&#148; shall mean that such
documents or information referenced: (i)&nbsp;were delivered to Parent or its Representatives prior to the execution and delivery of this Agreement; (ii)&nbsp;were contained in the Company&#146;s electronic data room maintained by Donnelley
Financial Solutions at least one (1)&nbsp;Business Day prior to the execution and delivery of this Agreement; or (iii)&nbsp;were publicly available on the EDGAR website at all times during the twenty-four (24)&nbsp;hours prior to the date of this
Agreement. The descriptive headings herein are inserted for convenience of reference only and are not intended to be part of or to affect the meaning or interpretation of this Agreement. The parties have participated jointly in the negotiation and
drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties and no presumption or burden of proof shall arise favoring or disfavoring
any Person by virtue of the authorship of any provision of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[REMAINDER OF PAGE INTENTIONALLY LEFT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BLANK SIGNATURE PAGES FOLLOW] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf by
its officer thereunto duly authorized, all at or on the date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="98%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ROCHE&nbsp;HOLDINGS,&nbsp;INC.</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="85%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bruce Resnick</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Bruce Resnick</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ABINGDON ACQUISITION CORP.</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="85%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bruce Resnick</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Bruce Resnick</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">IGNYTA, INC.</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="85%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jonathan Lim</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Jonathan Lim</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President and CEO</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Agreement and Plan of Merger] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ANNEX I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDITIONS TO THE OFFER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligation of Purchaser to accept for payment and pay for Company Shares validly tendered (and not withdrawn) pursuant to the Offer is
subject to the satisfaction of the conditions set forth in clauses&nbsp;(a) through (h)&nbsp;below. Accordingly, notwithstanding any other provision of the Offer and in addition to Purchaser&#146;s rights to extend, amend or terminate the Offer in
accordance with the provisions of the Agreement, Purchaser shall not be required to accept for payment or (subject to any applicable rules and regulations of the SEC, including <FONT STYLE="white-space:nowrap">Rule&nbsp;14e-1(c)</FONT> promulgated
under the Exchange Act) pay for, and may delay the acceptance for payment of, or (subject to any such rules and regulations) the payment for, any tendered Company Shares, and, to the extent permitted by this Agreement, may terminate the Offer:
(i)&nbsp;upon termination of this Agreement; and (ii)&nbsp;at any scheduled Expiration Date (subject to any extensions of the Offer pursuant to <U>Section</U><U></U><U>&nbsp;1.01(c)</U> of this Agreement), if: (A)&nbsp;the Minimum Condition shall
not be satisfied as of 11:59&nbsp;p.m. Eastern Time on the Expiration Date of the Offer; or (B)&nbsp;any of the other following conditions shall not be satisfied or (other than in the case of the conditions (d), (g) and (h)&nbsp;below) waived in
writing by Parent: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;there shall have been validly tendered and not withdrawn Company Shares (excluding any
Company Shares tendered pursuant to guaranteed delivery procedures that have not yet been delivered in settlement or satisfaction of such guarantee) that, considered together with all other Company Shares (if any) beneficially owned by Parent and
its Affiliates, represent a majority of the total number of Company Shares outstanding at the time of the expiration of the Offer (the &#147;<U>Minimum Condition</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;(i) each of the representations and warranties of the Company set forth in
<U>Section</U><U></U><U>&nbsp;3.02(a)</U> (Capitalization) and the first and second sentences of <U>Section</U><U></U><U>&nbsp;3.02(c)</U> (Capitalization) of this Agreement shall have been true and correct (except for only
<I>de</I><I></I><I>&nbsp;minimis</I> inaccuracies) as of the date of this Agreement and as of the Offer Acceptance Time as though made on and as of the Offer Acceptance Time (except to the extent such representations and warranties expressly relate
to an earlier date, in which case as of such earlier date); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;each of the representations and warranties of the
Company set forth in <U>Sections</U><U></U><U>&nbsp;3.01</U> (Organization and Qualification), <U>3.03</U> (Authority; Board Action), <U>Section</U><U></U><U>&nbsp;3.22</U> (Opinion of Financial Advisors), Section&nbsp;3.23 (Takeover Statutes) and
<U>Section</U><U></U><U>&nbsp;3.24</U> (No Vote Required) of this Agreement that is qualified as to materiality or Material Adverse Effect shall have been true and correct, and each that is not so qualified shall have been true in and correct in all
material respects, in all cases as of the date of this Agreement and as of the Offer Acceptance Time as though made on and as of the Offer Acceptance Time (except to the extent such representations and warranties expressly relate to an earlier date,
in which case as of such earlier date); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;each of the representations and warranties of the Company set forth
in this Agreement other than those referred to in clause &#147;(i)&#148; or &#147;(ii)&#148; of this clause&nbsp;(b), shall have been true and correct (without giving effect to any qualification as to materiality or Material Adverse
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-I-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Effect contained in <U>Article</U><U></U><U>&nbsp;III</U>) as of the date of this Agreement and as of the Offer Acceptance Time as though made on and as of the Offer Acceptance Time (except to
the extent such representations and warranties expressly relate to an earlier date, in which case as of such earlier date), except where any failures of any such representations and warranties to be true and correct have not resulted and would not
reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;the Company
shall have performed or complied in all material respects with all covenants and obligations required to be performed or complied with by it under this Agreement at or prior to the Offer Acceptance Time; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Any applicable waiting period (or extension thereof) relating to the Offer under the HSR Act and any applicable
Foreign Antitrust Laws shall have expired or been terminated and any approvals or clearances required thereunder shall have been obtained; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;since the date of this Agreement, the Company shall not have suffered any Material Adverse Effect and there shall
not have been any change, condition, event or development that would reasonably be expected to result, individually or in the aggregate, in a Material Adverse Effect; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Parent and Purchaser shall have received a certificate executed on behalf of the Company by its Chief Executive
Officer or Chief Financial Officer, acting in such capacity, and not in his or her capacity as individuals, confirming that the conditions set forth in clauses&nbsp;(b), (c) and (e)&nbsp;of this <U>Annex</U><U></U><U>&nbsp;I</U> have been duly
satisfied; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;no temporary restraining order, preliminary or permanent injunction or other order or decree issued
by any court of competent jurisdiction or other legal restraint or prohibition shall have been in effect, and no Law shall have been enacted, entered, promulgated or enforced by any Governmental Entity that, in any such case, prohibits or makes
illegal the acquisition of or payment for the Company Shares pursuant to the Offer, or the consummation of the Merger; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;this Agreement shall not have been terminated in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except for the Minimum Condition and conditions (d), (g) and (h)&nbsp;above, the foregoing conditions are for the sole benefit of Parent and Purchaser, may be
asserted by Parent or Purchaser and may be waived by Parent or Purchaser in whole or in part at any time and from time to time in the sole discretion of Parent or Purchaser, subject in each case to the terms of the Agreement and the applicable rules
and regulations of the SEC. The failure by Parent or Purchaser at any time to exercise any of the foregoing rights shall not be deemed a waiver of any such right and, each such right shall be deemed an ongoing right which may be asserted at any time
and from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-I-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ANNEX II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF TENDER AND SUPPORT AGREEMENT </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-II-1 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
